10/01/2026 | Press release | Distributed by Public on 10/01/2026 07:45
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM N-CSR
CERTIFIED SHAREHOLDER REPORT
OF
REGISTERED MANAGEMENT INVESTMENT COMPANIES
Investment Company Act file number: 811-03916
| Name of Registrant: | Vanguard Specialized Funds |
| Address of Registrant: | P.O. Box 2600 |
| Valley Forge, PA 19482 |
| Name and address of agent for service: | Natalie Lamarque, Esquire |
| P.O. Box 876 | |
| Valley Forge, PA 19482 |
Registrant's telephone number, including area code: (610) 669-1000
Date of fiscal year end: January 31
Date of reporting period: February 1, 2026-July 31, 2026
Item 1: Reports to Shareholders.
TABLE OF CONTENTS
|
Dividend Growth Fund |
|
|
Energy Opportunities Fund |
|
|
Energy Opportunities Fund |
|
|
Health Care Fund |
|
|
Health Care Fund |
|
|
Dividend Appreciation Index Fund |
|
|
Dividend Appreciation Index Fund |
|
Semi-Annual Shareholder Report | July 31, 2026
This semi-annual shareholder report contains important information about Vanguard Dividend Growth Fund (the "Fund") for the period of February 1, 2026, to July 31, 2026. You can find additional information about the Fund at https://personal1.vanguard.com/ngf-next-gen-form-webapp/fund-literature. You can also request this information by contacting us at 800-662-7447.
(based on a hypothetical $10,000 investment)
|
Share Class Name
|
Costs of a $10,000 investment
|
Costs paid as a percentage of a $10,000 investment
|
|
Investor Shares
|
$10
|
0.19%Footnote Reference1
|
| Footnote | Description |
|
Footnote1
|
Annualized. |
|
Fund Net Assets (in millions)
|
$35,481
|
|
Number of Portfolio Holdings
|
70
|
|
Portfolio Turnover Rate
|
25%
|
|
Communication Services
|
1.5%
|
|
Consumer Discretionary
|
7.7%
|
|
Consumer Staples
|
6.2%
|
|
Energy
|
2.7%
|
|
Financials
|
21.4%
|
|
Health Care
|
17.6%
|
|
Industrials
|
12.9%
|
|
Information Technology
|
24.7%
|
|
Materials
|
2.6%
|
|
Utilities
|
1.7%
|
|
Other Assets and Liabilities-Net
|
1.0%
|
This table reflects the Fund's investments, including short-term investments and other assets and liabilities.
Additional information about the Fund, including its prospectus, financial information, holdings, and proxy voting information is available at https://personal1.vanguard.com/ngf-next-gen-form-webapp/fund-literature.
Connect with Vanguard® • vanguard.com
Fund Information • 800-662-7447
Direct Investor Account Services • 800-662-2739
Text Telephone for People Who Are Deaf or Hard of Hearing •
800-749-7273
© 2026 The Vanguard Group, Inc.
All rights reserved.
Vanguard Marketing Corporation, Distributor.
SR57
Semi-Annual Shareholder Report | July 31, 2026
This semi-annual shareholder report contains important information about Vanguard Energy Opportunities Fund (the "Fund") (formerly known as Vanguard Energy Fund) for the period of February 1, 2026, to July 31, 2026. You can find additional information about the Fund at https://personal1.vanguard.com/ngf-next-gen-form-webapp/fund-literature. You can also request this information by contacting us at 800-662-7447.
(based on a hypothetical $10,000 investment)
|
Share Class Name
|
Costs of a $10,000 investment
|
Costs paid as a percentage of a $10,000 investment
|
|
Investor Shares
|
$23
|
0.44%Footnote Reference1
|
| Footnote | Description |
|
Footnote1
|
Annualized. |
|
Fund Net Assets (in millions)
|
$7,311
|
|
Number of Portfolio Holdings
|
43
|
|
Portfolio Turnover Rate
|
8%
|
|
Asia
|
2.8%
|
|
Europe
|
32.2%
|
|
North America
|
63.4%
|
|
South America
|
1.1%
|
|
Other Assets and Liabilities-Net
|
0.5%
|
This table reflects the Fund's investments, including short-term investments and other assets and liabilities.
Additional information about the Fund, including its prospectus, financial information, holdings, and proxy voting information is available at https://personal1.vanguard.com/ngf-next-gen-form-webapp/fund-literature.
Connect with Vanguard® • vanguard.com
Fund Information • 800-662-7447
Direct Investor Account Services • 800-662-2739
Text Telephone for People Who Are Deaf or Hard of Hearing •
800-749-7273
© 2026 The Vanguard Group, Inc.
All rights reserved.
Vanguard Marketing Corporation, Distributor.
SR51
Semi-Annual Shareholder Report | July 31, 2026
This semi-annual shareholder report contains important information about Vanguard Energy Opportunities Fund (the "Fund") (formerly known as Vanguard Energy Fund) for the period of February 1, 2026, to July 31, 2026. You can find additional information about the Fund at https://personal1.vanguard.com/ngf-next-gen-form-webapp/fund-literature. You can also request this information by contacting us at 800-662-7447.
(based on a hypothetical $10,000 investment)
|
Share Class Name
|
Costs of a $10,000 investment
|
Costs paid as a percentage of a $10,000 investment
|
|
Admiral Shares
|
$19
|
0.36%Footnote Reference1
|
| Footnote | Description |
|
Footnote1
|
Annualized. |
|
Fund Net Assets (in millions)
|
$7,311
|
|
Number of Portfolio Holdings
|
43
|
|
Portfolio Turnover Rate
|
8%
|
|
Asia
|
2.8%
|
|
Europe
|
32.2%
|
|
North America
|
63.4%
|
|
South America
|
1.1%
|
|
Other Assets and Liabilities-Net
|
0.5%
|
This table reflects the Fund's investments, including short-term investments and other assets and liabilities.
Additional information about the Fund, including its prospectus, financial information, holdings, and proxy voting information is available at https://personal1.vanguard.com/ngf-next-gen-form-webapp/fund-literature.
Connect with Vanguard® • vanguard.com
Fund Information • 800-662-7447
Direct Investor Account Services • 800-662-2739
Text Telephone for People Who Are Deaf or Hard of Hearing •
800-749-7273
© 2026 The Vanguard Group, Inc.
All rights reserved.
Vanguard Marketing Corporation, Distributor.
SR551
Semi-Annual Shareholder Report | July 31, 2026
This semi-annual shareholder report contains important information about Vanguard Health Care Fund (the "Fund") for the period of February 1, 2026, to July 31, 2026. You can find additional information about the Fund at https://personal1.vanguard.com/ngf-next-gen-form-webapp/fund-literature. You can also request this information by contacting us at 800-662-7447.
(based on a hypothetical $10,000 investment)
|
Share Class Name
|
Costs of a $10,000 investment
|
Costs paid as a percentage of a $10,000 investment
|
|
Investor Shares
|
$17
|
0.34%Footnote Reference1
|
| Footnote | Description |
|
Footnote1
|
Annualized. |
|
Fund Net Assets (in millions)
|
$38,166
|
|
Number of Portfolio Holdings
|
97
|
|
Portfolio Turnover Rate
|
24%
|
|
Asia
|
5.5%
|
|
Europe
|
18.2%
|
|
North America
|
74.1%
|
|
Other Assets and Liabilities-Net
|
2.2%
|
This table reflects the Fund's investments, including short-term investments and other assets and liabilities.
Additional information about the Fund, including its prospectus, financial information, holdings, and proxy voting information is available at https://personal1.vanguard.com/ngf-next-gen-form-webapp/fund-literature.
Connect with Vanguard® • vanguard.com
Fund Information • 800-662-7447
Direct Investor Account Services • 800-662-2739
Text Telephone for People Who Are Deaf or Hard of Hearing •
800-749-7273
© 2026 The Vanguard Group, Inc.
All rights reserved.
Vanguard Marketing Corporation, Distributor.
SR52
Semi-Annual Shareholder Report | July 31, 2026
This semi-annual shareholder report contains important information about Vanguard Health Care Fund (the "Fund") for the period of February 1, 2026, to July 31, 2026. You can find additional information about the Fund at https://personal1.vanguard.com/ngf-next-gen-form-webapp/fund-literature. You can also request this information by contacting us at 800-662-7447.
(based on a hypothetical $10,000 investment)
|
Share Class Name
|
Costs of a $10,000 investment
|
Costs paid as a percentage of a $10,000 investment
|
|
Admiral Shares
|
$14
|
0.28%Footnote Reference1
|
| Footnote | Description |
|
Footnote1
|
Annualized. |
|
Fund Net Assets (in millions)
|
$38,166
|
|
Number of Portfolio Holdings
|
97
|
|
Portfolio Turnover Rate
|
24%
|
|
Asia
|
5.5%
|
|
Europe
|
18.2%
|
|
North America
|
74.1%
|
|
Other Assets and Liabilities-Net
|
2.2%
|
This table reflects the Fund's investments, including short-term investments and other assets and liabilities.
Additional information about the Fund, including its prospectus, financial information, holdings, and proxy voting information is available at https://personal1.vanguard.com/ngf-next-gen-form-webapp/fund-literature.
Connect with Vanguard® • vanguard.com
Fund Information • 800-662-7447
Direct Investor Account Services • 800-662-2739
Text Telephone for People Who Are Deaf or Hard of Hearing •
800-749-7273
© 2026 The Vanguard Group, Inc.
All rights reserved.
Vanguard Marketing Corporation, Distributor.
SR552
Semi-Annual Shareholder Report | July 31, 2026
This semi-annual shareholder report contains important information about Vanguard Dividend Appreciation Index Fund (the "Fund") for the period of February 1, 2026, to July 31, 2026. You can find additional information about the Fund at https://personal1.vanguard.com/ngf-next-gen-form-webapp/fund-literature. You can also request this information by contacting us at 800-662-7447.
(based on a hypothetical $10,000 investment)
|
Share Class Name
|
Costs of a $10,000 investment
|
Costs paid as a percentage of a $10,000 investment
|
|
ETF Shares
|
$2
|
0.04%Footnote Reference1
|
| Footnote | Description |
|
Footnote1
|
Annualized. |
|
Fund Net Assets (in millions)
|
$130,900
|
|
Number of Portfolio Holdings
|
340
|
|
Portfolio Turnover Rate
|
4%
|
|
Consumer Discretionary
|
4.2%
|
|
Consumer Staples
|
9.3%
|
|
Energy
|
3.3%
|
|
Financials
|
21.8%
|
|
Health Care
|
17.7%
|
|
Industrials
|
11.9%
|
|
Information Technology
|
25.3%
|
|
Materials
|
3.2%
|
|
Utilities
|
2.9%
|
|
Other Assets and Liabilities-Net
|
0.4%
|
This table reflects the Fund's investments, including short-term investments, derivatives and other assets and liabilities.
Additional information about the Fund, including its prospectus, financial information, holdings, and proxy voting information is available at https://personal1.vanguard.com/ngf-next-gen-form-webapp/fund-literature.
Connect with Vanguard® • vanguard.com
Fund Information • 800-662-7447
Direct Investor Account Services • 800-662-2739
Text Telephone for People Who Are Deaf or Hard of Hearing •
800-749-7273
© 2026 The Vanguard Group, Inc.
All rights reserved.
Vanguard Marketing Corporation, Distributor.
SR920
Semi-Annual Shareholder Report | July 31, 2026
This semi-annual shareholder report contains important information about Vanguard Dividend Appreciation Index Fund (the "Fund") for the period of February 1, 2026, to July 31, 2026. You can find additional information about the Fund at https://personal1.vanguard.com/ngf-next-gen-form-webapp/fund-literature. You can also request this information by contacting us at 800-662-7447.
(based on a hypothetical $10,000 investment)
|
Share Class Name
|
Costs of a $10,000 investment
|
Costs paid as a percentage of a $10,000 investment
|
|
Admiral Shares
|
$4
|
0.07%Footnote Reference1
|
| Footnote | Description |
|
Footnote1
|
Annualized. |
|
Fund Net Assets (in millions)
|
$130,900
|
|
Number of Portfolio Holdings
|
340
|
|
Portfolio Turnover Rate
|
4%
|
|
Consumer Discretionary
|
4.2%
|
|
Consumer Staples
|
9.3%
|
|
Energy
|
3.3%
|
|
Financials
|
21.8%
|
|
Health Care
|
17.7%
|
|
Industrials
|
11.9%
|
|
Information Technology
|
25.3%
|
|
Materials
|
3.2%
|
|
Utilities
|
2.9%
|
|
Other Assets and Liabilities-Net
|
0.4%
|
This table reflects the Fund's investments, including short-term investments, derivatives and other assets and liabilities.
Additional information about the Fund, including its prospectus, financial information, holdings, and proxy voting information is available at https://personal1.vanguard.com/ngf-next-gen-form-webapp/fund-literature.
Connect with Vanguard® • vanguard.com
Fund Information • 800-662-7447
Direct Investor Account Services • 800-662-2739
Text Telephone for People Who Are Deaf or Hard of Hearing •
800-749-7273
© 2026 The Vanguard Group, Inc.
All rights reserved.
Vanguard Marketing Corporation, Distributor.
SR5702
Item 2: Code of Ethics.
Not applicable.
Item 3: Audit Committee Financial Expert.
Not applicable.
Item 4: Principal Accountant Fees and Services.
Not applicable.
Item 5: Audit Committee of Listed Registrants.
Not applicable.
Item 6: Investments.
Not applicable. The complete schedule of investments is included in the financial statements filed under Item 7 of this Form.
Item 7: Financial Statements and Financial Highlights for Open-End Management Investment Companies.
|
Financial Statements
|
1
|
|
|
|
|
|
|
Shares
|
Market
Value•
($000)
|
|
Common Stocks (99.0%)
|
|||
|
Communication Services (1.5%)
|
|||
|
|
Alphabet Inc. Class A
|
1,489,258
|
530,369
|
|
Consumer Discretionary (7.7%)
|
|||
|
|
Home Depot Inc.
|
2,636,912
|
875,349
|
|
|
TJX Cos. Inc.
|
5,068,526
|
797,482
|
|
|
McDonald's Corp.
|
1,514,980
|
410,014
|
|
|
Marriott International Inc. Class A
|
1,006,301
|
375,179
|
|
|
NIKE Inc. Class B
|
6,852,981
|
285,838
|
|
|
|
|
2,743,862
|
|
Consumer Staples (6.2%)
|
|||
|
|
Coca-Cola Co.
|
7,303,254
|
639,692
|
|
|
Unilever plc
|
7,058,887
|
449,140
|
|
|
Procter & Gamble Co.
|
2,822,324
|
407,798
|
|
|
PepsiCo Inc.
|
1,383,735
|
193,114
|
|
|
Walmart Inc.
|
1,602,004
|
178,143
|
|
*
|
US Foods Holding Corp.
|
1,449,905
|
145,846
|
|
|
Colgate-Palmolive Co.
|
1,345,935
|
122,884
|
|
|
Kroger Co.
|
881,025
|
50,870
|
|
|
|
|
2,187,487
|
|
Energy (2.7%)
|
|||
|
|
ExxonMobil Holdings Corp.
|
4,275,096
|
664,521
|
|
|
TotalEnergies SE (XNYS) ADR
|
3,422,073
|
300,663
|
|
|
|
|
965,184
|
|
Financials (21.4%)
|
|||
|
|
Mastercard Inc. Class A
|
2,466,952
|
1,413,810
|
|
|
Visa Inc. Class A (XNYS)
|
3,355,458
|
1,228,534
|
|
|
Blackrock Inc.
|
970,963
|
1,058,729
|
|
|
Wells Fargo & Co.
|
11,550,584
|
998,548
|
|
|
Marsh & McLennan Cos. Inc.
|
4,623,171
|
876,969
|
|
|
Chubb Ltd.
|
2,121,141
|
743,842
|
|
|
JPMorgan Chase & Co. (XNYS)
|
1,829,631
|
643,646
|
|
|
S&P Global Inc.
|
816,479
|
336,332
|
|
|
UBS Group AG (Registered)
|
5,740,784
|
303,444
|
|
|
|
|
7,603,854
|
|
Health Care (17.6%)
|
|||
|
|
Eli Lilly & Co.
|
1,438,568
|
1,652,684
|
|
|
Merck & Co. Inc.
|
7,319,240
|
952,965
|
|
|
Stryker Corp.
|
2,235,827
|
728,209
|
|
|
Danaher Corp.
|
3,526,208
|
687,540
|
|
|
Johnson & Johnson
|
2,515,972
|
644,969
|
|
|
Amgen Inc.
|
1,359,131
|
523,483
|
|
|
Elevance Health Inc. (XNYS)
|
1,261,543
|
474,138
|
|
|
Cardinal Health Inc.
|
1,476,901
|
339,732
|
|
|
AbbVie Inc.
|
763,096
|
191,491
|
|
|
AstraZeneca plc ADR
|
189,516
|
32,150
|
|
|
|
|
6,227,361
|
|
Industrials (12.9%)
|
|||
|
|
Automatic Data Processing Inc.
|
3,198,960
|
852,395
|
|
|
Northrop Grumman Corp.
|
1,162,288
|
630,518
|
|
|
Trane Technologies plc
|
1,189,724
|
541,265
|
|
|
AMETEK Inc.
|
2,009,236
|
485,652
|
|
|
Honeywell International Inc.
|
1,976,001
|
480,267
|
|
|
Canadian National Railway Co.
|
3,327,692
|
423,127
|
|
*
|
Honeywell Aerospace Inc.
|
1,976,001
|
408,519
|
|
|
Caterpillar Inc. (XNYS)
|
434,270
|
353,848
|
|
|
Deere & Co.
|
596,545
|
353,554
|
|
|
Waste Management Inc.
|
77,639
|
17,589
|
|
|
Rollins Inc.
|
399,038
|
15,152
|
|
|
|
Shares
|
Market
Value•
($000)
|
|
|
CH Robinson Worldwide Inc.
|
94,429
|
13,950
|
|
|
|
|
4,575,836
|
|
Information Technology (24.7%)
|
|||
|
|
Broadcom Inc.
|
5,352,977
|
2,083,807
|
|
|
Microsoft Corp.
|
4,415,608
|
2,052,021
|
|
|
Apple Inc.
|
3,819,120
|
1,179,765
|
|
|
Texas Instruments Inc.
|
3,834,345
|
1,057,282
|
|
|
KLA Corp.
|
3,576,072
|
653,778
|
|
|
Amphenol Corp. Class A
|
3,941,906
|
633,464
|
|
|
International Business Machines Corp.
|
1,534,693
|
343,234
|
|
|
QUALCOMM Inc.
|
2,053,830
|
303,166
|
|
|
ASML Holding NV GDR (Registered)
|
142,807
|
232,633
|
|
|
NVIDIA Corp.
|
1,112,425
|
223,319
|
|
|
|
|
8,762,469
|
|
Materials (2.6%)
|
|||
|
|
Linde plc
|
1,711,385
|
818,692
|
|
*
|
Glencore plc
|
15,353,310
|
113,083
|
|
|
|
|
931,775
|
|
Utilities (1.7%)
|
|||
|
|
American Water Works Co. Inc.
|
2,716,844
|
364,519
|
|
|
Sempra
|
1,947,863
|
172,483
|
|
|
Dominion Energy Inc.
|
774,751
|
53,590
|
|
|
|
|
590,592
|
|
Total Common Stocks (Cost $20,022,285)
|
35,118,789
|
||
|
Temporary Cash Investments (1.1%)
|
|||
|
Money Market Fund (0.0%)
|
|||
|
1
|
Vanguard Market Liquidity Fund, 3.718%
|
262
|
26
|
|
|
|
Face
Amount
($000)
|
|
|
Repurchase Agreements (1.1%)
|
|||
|
|
Bank of America Securities, LLC 3.650%, 8/3/2026
(Dated 7/31/2026, Repurchase Value $20,006, collateralized by U.S. Treasury Obligations 0.000%-4.625%, 8/6/2026-11/15/2055, with a
value of $20,400)
|
20,000
|
20,000
|
|
|
Bank of America Securities, LLC 3.660%, 8/3/2026
(Dated 7/31/2026, Repurchase Value $35,011, collateralized by U.S. Government Agency Obligations 3.000%-6.000%,
12/1/2040-4/1/2056, with a value of $35,700)
|
35,000
|
35,000
|
|
|
Credit Agricole Securities 3.640%, 8/3/2026
(Dated 7/31/2026, Repurchase Value $77,323, collateralized by U.S. Treasury and Government Agency Obligations 0.000%-5.400%,
10/31/2026-8/15/2054, with a value of $78,846)
|
77,300
|
77,300
|
|
|
JP Morgan Securities, LLC 3.640%, 8/3/2026
(Dated 7/31/2026, Repurchase Value $55,017, collateralized by U.S. Treasury Obligations 4.625%, 6/15/2027, with a value of $56,100)
|
55,000
|
55,000
|
|
|
Natixis SA 3.640%, 8/3/2026
(Dated 7/31/2026, Repurchase Value $64,119, collateralized by U.S. Treasury and Government Agency Obligations 0.500%-4.875%,
12/31/2026-11/15/2055, with a value of $65,382)
|
64,100
|
64,100
|
|
|
Nomura International plc 3.640%, 8/3/2026
(Dated 7/31/2026, Repurchase Value $75,023, collateralized by U.S. Treasury Obligations 3.750%-4.250%, 7/31/2028-5/31/2031, with a
value of $76,500)
|
75,000
|
75,000
|
|
|
Societe Generale 3.640%, 8/3/2026
(Dated 7/31/2026, Repurchase Value $75,723, collateralized by U.S. Treasury Obligations 3.375%-4.625%, 2/15/2040-8/15/2042, with a
value of $77,214)
|
75,700
|
75,700
|
|
|
|
|
402,100
|
|
Total Temporary Cash Investments (Cost $402,126)
|
402,126
|
||
|
Total Investments (100.1%) (Cost $20,424,411)
|
35,520,915
|
||
|
Other Assets and Liabilities-Net (-0.1%)
|
(40,139)
|
||
|
Net Assets (100%)
|
35,480,776
|
||
|
Cost is in $000.
|
|||
|
•
|
See Note A in Notes to Financial Statements.
|
|
*
|
Non-income-producing security.
|
|
1
|
Affiliated money market fund available only to Vanguard funds and certain trusts and accounts managed by Vanguard. Rate shown is the 7-day yield.
|
|
|
ADR-American Depositary Receipt.
|
|
|
GDR-Global Depositary Receipt.
|
|
|
|
|
($000s, except shares and per-share amounts)
|
Amount
|
|
Assets
|
|
|
Investments in Securities, at Value
|
|
|
Unaffiliated Issuers (Cost $20,424,385)
|
35,520,889
|
|
Affiliated Issuers (Cost $26)
|
26
|
|
Total Investments in Securities
|
35,520,915
|
|
Investment in Vanguard
|
763
|
|
Cash
|
40
|
|
Foreign Currency, at Value (Cost $29)
|
29
|
|
Receivables for Investment Securities Sold
|
124,574
|
|
Receivables for Accrued Income
|
23,694
|
|
Receivables for Capital Shares Issued
|
3,185
|
|
Total Assets
|
35,673,200
|
|
Liabilities
|
|
|
Payables for Investment Securities Purchased
|
160,617
|
|
Payables to Investment Advisor
|
4,000
|
|
Payables for Capital Shares Redeemed
|
25,629
|
|
Payables to Vanguard
|
2,178
|
|
Total Liabilities
|
192,424
|
|
Net Assets
|
35,480,776
|
|
At July 31, 2026, net assets consisted of:
|
|
|
|
|
|
Paid-in Capital
|
16,999,515
|
|
Total Distributable Earnings (Loss)
|
18,481,261
|
|
Net Assets
|
35,480,776
|
|
|
|
|
Net Assets
|
|
|
Applicable to 1,112,031,391 outstanding $.001 par value shares of
beneficial interest (unlimited authorization)
|
35,480,776
|
|
Net Asset Value Per Share
|
$31.91
|
|
|
|
|
|
Six Months Ended
July 31, 2026
|
|
|
($000)
|
|
Investment Income
|
|
|
Income
|
|
|
Dividends1
|
272,431
|
|
Interest
|
7,619
|
|
Securities Lending-Net
|
1
|
|
Total Income
|
280,051
|
|
Expenses
|
|
|
Investment Advisory Fees-Note B
|
|
|
Basic Fee
|
24,265
|
|
Performance Adjustment
|
(15,674
)
|
|
The Vanguard Group-Note C
|
|
|
Management and Administrative
|
24,242
|
|
Marketing and Distribution
|
977
|
|
Custodian Fees
|
119
|
|
Shareholders' Reports
|
167
|
|
Trustees' Fees and Expenses
|
9
|
|
Other Expenses
|
73
|
|
Total Expenses
|
34,178
|
|
Expenses Paid Indirectly
|
(44
)
|
|
Net Expenses
|
34,134
|
|
Net Investment Income
|
245,917
|
|
Realized Net Gain (Loss)
|
|
|
Investment Securities Sold2
|
3,404,368
|
|
Foreign Currencies
|
(155
)
|
|
Realized Net Gain (Loss)
|
3,404,213
|
|
Change in Unrealized Appreciation (Depreciation)
|
|
|
Investment Securities2
|
(2,340,987
)
|
|
Foreign Currencies
|
(81
)
|
|
Change in Unrealized Appreciation (Depreciation)
|
(2,341,068
)
|
|
Net Increase (Decrease) in Net Assets Resulting from Operations
|
1,309,062
|
|
1
|
Dividends are net of foreign withholding taxes of $1,162.
|
|
2
|
Change in unrealized appreciation (depreciation) from an affiliated company of the fund was less than $1. There was no realized net gain (loss) during the period. Purchases and sales are for temporary cash investment
purposes.
|
|
|
||
|
|
Six Months Ended
July 31,
2026
|
Year Ended
January 31,
2026
|
|
|
($000)
|
($000)
|
|
Increase (Decrease) in Net Assets
|
||
|
Operations
|
||
|
Net Investment Income
|
245,917
|
685,976
|
|
Realized Net Gain (Loss)
|
3,404,213
|
8,742,302
|
|
Change in Unrealized Appreciation (Depreciation)
|
(2,341,068
)
|
(6,632,028
)
|
|
Net Increase (Decrease) in Net Assets Resulting from Operations
|
1,309,062
|
2,796,250
|
|
Distributions
|
||
|
Total Distributions
|
(2,716,738
)
|
(7,277,528
)
|
|
Capital Share Transactions
|
||
|
Issued
|
542,862
|
2,455,621
|
|
Issued in Lieu of Cash Distributions
|
2,382,302
|
6,339,899
|
|
Redeemed
|
(6,376,040
)
|
(14,399,407
)
|
|
Net Increase (Decrease) from Capital Share Transactions
|
(3,450,876
)
|
(5,603,887
)
|
|
Total Increase (Decrease)
|
(4,858,552
)
|
(10,085,165
)
|
|
Net Assets
|
||
|
Beginning of Period
|
40,339,328
|
50,424,493
|
|
End of Period
|
35,480,776
|
40,339,328
|
|
For a Share Outstanding
Throughout Each Period
|
Six Months
Ended
July 31,
2026
|
Year Ended January 31,
|
||||
|
2026
|
2025
|
2024
|
2023
|
2022
|
||
|
Net Asset Value, Beginning of Period
|
$33.16
|
$37.14
|
$37.76
|
$35.42
|
$37.85
|
$31.82
|
|
Investment Operations
|
||||||
|
Net Investment Income1
|
.209
|
.540
|
.658
|
.620
|
.596
|
.576
|
|
Net Realized and Unrealized Gain (Loss) on Investments
|
.863
|
1.769
|
3.053
|
2.573
|
(.893)
|
7.593
|
|
Total from Investment Operations
|
1.072
|
2.309
|
3.711
|
3.193
|
(.297)
|
8.169
|
|
Distributions
|
||||||
|
Dividends from Net Investment Income
|
(.239)
|
(.577)
|
(.679)
|
(.629)
|
(.590)
|
(.574)
|
|
Distributions from Realized Capital Gains
|
(2.083)
|
(5.712)
|
(3.652)
|
(.224)
|
(1.543)
|
(1.565)
|
|
Total Distributions
|
(2.322)
|
(6.289)
|
(4.331)
|
(.853)
|
(2.133)
|
(2.139)
|
|
Net Asset Value, End of Period
|
$31.91
|
$33.16
|
$37.14
|
$37.76
|
$35.42
|
$37.85
|
|
Total Return2
|
4.08%
|
6.58%
|
10.20%
|
9.11%
|
-0.76%
|
25.66%
|
|
Ratios/Supplemental Data
|
|
|
|
|
|
|
|
Net Assets, End of Period (Millions)
|
$35,481
|
$40,339
|
$50,424
|
$52,553
|
$53,452
|
$54,186
|
|
Ratio of Total Expenses to Average Net Assets3
|
0.19%4
|
0.20%4
|
0.22%5
|
0.29%5
|
0.30%5
|
0.27%
|
|
Ratio of Net Investment Income to Average Net Assets
|
1.34%
|
1.50%
|
1.68%
|
1.74%
|
1.68%
|
1.56%
|
|
Portfolio Turnover Rate
|
25%
|
40%
|
16%
|
9%
|
11%
|
15%
|
|
The expense ratio and net investment income ratio for the current period have been annualized.
|
||||||
|
1
|
Calculated based on average shares outstanding.
|
|
2
|
Total returns do not include account service fees that may have applied in the periods shown. Fund prospectuses provide information about any applicable account service fees.
|
|
3
|
Includes performance-based investment advisory fee increases (decreases) of (0.09%), (0.07%), (0.05%), 0.02%, 0.03%, and (0.00%).
|
|
4
|
The ratio of expenses to average net assets for the period net of reduction from broker commission abatement arrangements was 0.19% and 0.20%, respectively.
|
|
5
|
The ratio of expenses to average net assets for the period net of reduction from custody fee offset and broker commission abatement arrangements was 0.22%, 0.29%, and 0.30%, respectively.
|
|
|
Level 1
($000)
|
Level 2
($000)
|
Level 3
($000)
|
Total
($000)
|
|
Investments
|
|
|
|
|
|
Assets
|
|
|
|
|
|
Common Stocks
|
34,253,122
|
865,667
|
-
|
35,118,789
|
|
Temporary Cash Investments
|
26
|
402,100
|
-
|
402,126
|
|
Total
|
34,253,148
|
1,267,767
|
-
|
35,520,915
|
|
|
Amount
($000)
|
|
Tax Cost
|
20,433,158
|
|
Gross Unrealized Appreciation
|
15,307,570
|
|
Gross Unrealized Depreciation
|
(219,813)
|
|
Net Unrealized Appreciation (Depreciation)
|
15,087,757
|
|
|
Six Months
Ended
July 31, 2026
|
Year Ended
January 31,
2026
|
|
|
Shares
(000)
|
Shares
(000)
|
|
Issued
|
17,279
|
69,573
|
|
Issued in Lieu of Cash Distributions
|
83,196
|
189,599
|
|
Redeemed
|
(204,906)
|
(400,538)
|
|
Net Increase (Decrease) in Shares Outstanding
|
(104,431)
|
(141,366)
|
|
Financial Statements
|
1
|
|
|
|
|
|
|
Shares
|
Market
Value•
($000)
|
|
Common Stocks (99.5%)
|
|||
|
Brazil (1.1%)
|
|||
|
|
Petroleo Brasileiro SA - Petrobras
|
8,559,325
|
82,805
|
|
Canada (0.5%)
|
|||
|
|
Cameco Corp.
|
453,660
|
39,187
|
|
France (11.8%)
|
|||
|
|
Engie SA (XPAR)
|
11,289,219
|
351,897
|
|
|
TotalEnergies SE (TQEX)
|
3,597,462
|
317,154
|
|
|
TotalEnergies SE (XNYS) ADR
|
2,202,526
|
193,514
|
|
|
|
|
862,565
|
|
Germany (2.2%)
|
|||
|
|
E.ON SE
|
7,573,211
|
163,152
|
|
India (1.7%)
|
|||
|
|
Reliance Industries Ltd.
|
5,458,905
|
74,740
|
|
|
Power Grid Corp. of India Ltd.
|
17,220,012
|
51,260
|
|
|
|
|
126,000
|
|
Italy (4.0%)
|
|||
|
|
Enel SpA
|
15,448,382
|
174,465
|
|
|
Tenaris SA ADR
|
1,720,815
|
98,654
|
|
|
Tenaris SA
|
681,309
|
19,547
|
|
|
|
|
292,666
|
|
Japan (1.1%)
|
|||
|
|
Kansai Electric Power Co. Inc.
|
5,108,178
|
77,361
|
|
Norway (1.4%)
|
|||
|
|
Equinor ASA
|
1,944,139
|
79,808
|
|
|
Equinor ASA ADR
|
622,430
|
25,582
|
|
|
|
|
105,390
|
|
Russia (0.0%)
|
|||
|
*,1
|
LUKOIL PJSC ADR
|
1,423,477
|
-
|
|
Spain (1.5%)
|
|||
|
|
Iberdrola SA
|
4,437,206
|
105,399
|
|
United Kingdom (11.3%)
|
|||
|
|
Shell plc (XLON)
|
8,086,763
|
370,145
|
|
|
National Grid plc
|
12,784,719
|
204,630
|
|
|
SSE plc
|
5,389,181
|
170,263
|
|
*
|
Glencore plc
|
11,089,583
|
81,679
|
|
|
|
|
826,717
|
|
United States (62.9%)
|
|||
|
|
ExxonMobil Holdings Corp.
|
4,196,279
|
652,270
|
|
|
Chevron Corp.
|
1,548,721
|
304,835
|
|
|
Targa Resources Corp.
|
1,120,381
|
302,917
|
|
|
Shell plc ADR
|
3,149,741
|
289,713
|
|
|
Williams Cos. Inc.
|
3,773,636
|
269,966
|
|
|
Dominion Energy Inc.
|
3,773,885
|
261,040
|
|
|
Sempra
|
2,916,432
|
258,250
|
|
|
Devon Energy Corp.
|
5,510,351
|
248,682
|
|
|
Diamondback Energy Inc.
|
1,209,971
|
245,564
|
|
|
American Electric Power Co. Inc.
|
1,754,930
|
224,368
|
|
|
Duke Energy Corp.
|
1,771,348
|
222,180
|
|
|
Southern Co.
|
2,316,559
|
219,007
|
|
|
Marathon Petroleum Corp.
|
674,008
|
213,303
|
|
|
Phillips 66
|
960,443
|
203,307
|
|
|
NextEra Energy Inc.
|
2,146,224
|
186,550
|
|
|
Cheniere Energy Inc.
|
576,887
|
152,050
|
|
|
|
Shares
|
Market
Value•
($000)
|
|
|
Atmos Energy Corp.
|
680,974
|
117,659
|
|
|
Exelon Corp.
|
2,515,096
|
115,242
|
|
|
Constellation Energy Corp.
|
194,178
|
51,020
|
|
|
Vistra Corp.
|
293,794
|
43,537
|
|
|
CMS Energy Corp.
|
188,376
|
13,561
|
|
|
|
|
4,595,021
|
|
Total Common Stocks (Cost $4,699,425)
|
7,276,263
|
||
|
Temporary Cash Investments (0.5%)
|
|||
|
Money Market Fund (0.0%)
|
|||
|
2
|
Vanguard Market Liquidity Fund, 3.718%
|
596
|
59
|
|
|
|
Face
Amount
($000)
|
|
|
Repurchase Agreement (0.5%)
|
|||
|
|
NatWest Markets plc, 3.640%, 8/3/2026
(Dated 7/31/2026, Repurchase Value $36,611, collateralized by U.S. Treasury Obligations 3.500%, 10/31/2027, with a value of $37,332)
|
36,600
|
36,600
|
|
Total Temporary Cash Investments (Cost $36,659)
|
36,659
|
||
|
Total Investments (100.0%) (Cost $4,736,084)
|
7,312,922
|
||
|
Other Assets and Liabilities-Net (0.0%)
|
(2,362)
|
||
|
Net Assets (100%)
|
7,310,560
|
||
|
Cost is in $000.
|
|||
|
•
|
See Note A in Notes to Financial Statements.
|
|
*
|
Non-income-producing security.
|
|
1
|
Security value determined using significant unobservable inputs.
|
|
2
|
Affiliated money market fund available only to Vanguard funds and certain trusts and accounts managed by Vanguard. Rate shown is the 7-day yield.
|
|
|
ADR-American Depositary Receipt.
|
|
|
|
|
($000s, except shares and per-share amounts)
|
Amount
|
|
Assets
|
|
|
Investments in Securities, at Value
|
|
|
Unaffiliated Issuers (Cost $4,736,025)
|
7,312,863
|
|
Affiliated Issuers (Cost $59)
|
59
|
|
Total Investments in Securities
|
7,312,922
|
|
Investment in Vanguard
|
148
|
|
Cash
|
3
|
|
Foreign Currency, at Value (Cost $1,310)
|
1,324
|
|
Receivables for Accrued Income
|
7,222
|
|
Receivables for Capital Shares Issued
|
3,031
|
|
Other Assets
|
32
|
|
Total Assets
|
7,324,682
|
|
Liabilities
|
|
|
Payables to Investment Advisor
|
3,453
|
|
Payables for Capital Shares Redeemed
|
4,094
|
|
Payables to Vanguard
|
813
|
|
Deferred Foreign Capital Gains Taxes
|
5,762
|
|
Total Liabilities
|
14,122
|
|
Net Assets
|
7,310,560
|
|
At July 31, 2026, net assets consisted of:
|
|
|
|
|
|
Paid-in Capital
|
4,496,312
|
|
Total Distributable Earnings (Loss)
|
2,814,248
|
|
Net Assets
|
7,310,560
|
|
|
|
|
Investor Shares-Net Assets
|
|
|
Applicable to 32,627,892 outstanding $.001 par value shares of
beneficial interest (unlimited authorization)
|
1,939,692
|
|
Net Asset Value Per Share-Investor Shares
|
$59.45
|
|
|
|
|
Admiral™ Shares-Net Assets
|
|
|
Applicable to 48,137,874 outstanding $.001 par value shares of
beneficial interest (unlimited authorization)
|
5,370,868
|
|
Net Asset Value Per Share-Admiral Shares
|
$111.57
|
|
|
|
|
|
Six Months Ended
July 31, 2026
|
|
|
($000)
|
|
Investment Income
|
|
|
Income
|
|
|
Dividends1
|
128,115
|
|
Interest
|
1,045
|
|
Securities Lending-Net
|
11
|
|
Total Income
|
129,171
|
|
Expenses
|
|
|
Investment Advisory Fees-Note B
|
|
|
Basic Fee
|
5,420
|
|
Performance Adjustment
|
1,506
|
|
The Vanguard Group-Note C
|
|
|
Management and Administrative-Investor Shares
|
2,321
|
|
Management and Administrative-Admiral Shares
|
3,942
|
|
Marketing and Distribution-Investor Shares
|
63
|
|
Marketing and Distribution-Admiral Shares
|
103
|
|
Custodian Fees
|
43
|
|
Shareholders' Reports-Investor Shares
|
31
|
|
Shareholders' Reports-Admiral Shares
|
20
|
|
Trustees' Fees and Expenses
|
2
|
|
Other Expenses
|
198
|
|
Total Expenses
|
13,649
|
|
Expenses Paid Indirectly
|
(15
)
|
|
Net Expenses
|
13,634
|
|
Net Investment Income
|
115,537
|
|
Realized Net Gain (Loss)
|
|
|
Investment Securities Sold2,3
|
133,569
|
|
Foreign Currencies
|
(117
)
|
|
Realized Net Gain (Loss)
|
133,452
|
|
Change in Unrealized Appreciation (Depreciation)
|
|
|
Investment Securities2,4
|
689,305
|
|
Foreign Currencies
|
(205
)
|
|
Change in Unrealized Appreciation (Depreciation)
|
689,100
|
|
Net Increase (Decrease) in Net Assets Resulting from Operations
|
938,089
|
|
1
|
Dividends are net of foreign withholding taxes of $2,945.
|
|
2
|
Realized net gain (loss) and change in unrealized appreciation (depreciation) from an affiliated company of the fund were ($1) and less than $1, respectively. Purchases and sales are for temporary cash investment
purposes.
|
|
3
|
Realized gain (loss) is net of foreign capital gain taxes of $177.
|
|
4
|
The change in unrealized appreciation (depreciation) is net of the change in deferred foreign capital gains taxes of ($568).
|
|
|
||
|
|
Six Months Ended
July 31,
2026
|
Year Ended
January 31,
2026
|
|
|
($000)
|
($000)
|
|
Increase (Decrease) in Net Assets
|
||
|
Operations
|
||
|
Net Investment Income
|
115,537
|
205,123
|
|
Realized Net Gain (Loss)
|
133,452
|
320,986
|
|
Change in Unrealized Appreciation (Depreciation)
|
689,100
|
945,471
|
|
Net Increase (Decrease) in Net Assets Resulting from Operations
|
938,089
|
1,471,580
|
|
Distributions
|
||
|
Investor Shares
|
(68,132
)
|
(81,652
)
|
|
Admiral Shares
|
(159,215
)
|
(199,527
)
|
|
Total Distributions
|
(227,347
)
|
(281,179
)
|
|
Capital Share Transactions
|
||
|
Investor Shares
|
(214,782
)
|
(228,060
)
|
|
Admiral Shares
|
183,693
|
86,706
|
|
Net Increase (Decrease) from Capital Share Transactions
|
(31,089
)
|
(141,354
)
|
|
Total Increase (Decrease)
|
679,653
|
1,049,047
|
|
Net Assets
|
||
|
Beginning of Period
|
6,630,907
|
5,581,860
|
|
End of Period
|
7,310,560
|
6,630,907
|
|
Investor Shares
|
|
|
|
|
|
|
|
For a Share Outstanding
Throughout Each Period
|
Six Months
Ended
July 31,
2026
|
Year Ended January 31,
|
||||
|
2026
|
2025
|
2024
|
2023
|
2022
|
||
|
Net Asset Value, Beginning of Period
|
$53.66
|
$44.04
|
$45.21
|
$46.43
|
$41.64
|
$31.66
|
|
Investment Operations
|
||||||
|
Net Investment Income1
|
.908
|
1.646
|
1.771
|
1.878
|
2.099
|
1.364
|
|
Net Realized and Unrealized Gain (Loss) on Investments
|
6.704
|
10.310
|
5.270
|
.080
|
4.807
|
10.019
|
|
Total from Investment Operations
|
7.612
|
11.956
|
7.041
|
1.958
|
6.906
|
11.383
|
|
Distributions
|
||||||
|
Dividends from Net Investment Income
|
-
|
(1.689)
|
(1.685)
|
(1.952)
|
(2.116)
|
(1.403)
|
|
Distributions from Realized Capital Gains
|
(1.822)
|
(.647)
|
(6.526)
|
(1.226)
|
-
|
-
|
|
Total Distributions
|
(1.822)
|
(2.336)
|
(8.211)
|
(3.178)
|
(2.116)
|
(1.403)
|
|
Net Asset Value, End of Period
|
$59.45
|
$53.66
|
$44.04
|
$45.21
|
$46.43
|
$41.64
|
|
Total Return2
|
14.17%
|
27.60%
|
16.24%
|
4.00%
|
16.72%
|
36.33%
|
|
Ratios/Supplemental Data
|
|
|
|
|
|
|
|
Net Assets, End of Period (Millions)
|
$1,940
|
$1,954
|
$1,815
|
$1,775
|
$1,950
|
$1,771
|
|
Ratio of Total Expenses to Average Net Assets3
|
0.44%4
|
0.45%4
|
0.45%5
|
0.44%5
|
0.46%5
|
0.41%
|
|
Ratio of Net Investment Income to Average Net Assets
|
3.13%
|
3.41%
|
3.62%
|
4.02%
|
4.70%
|
3.68%
|
|
Portfolio Turnover Rate
|
8%
|
19%
|
36%
|
29%
|
16%
|
14%
|
|
The expense ratio and net investment income ratio for the current period have been annualized.
|
||||||
|
1
|
Calculated based on average shares outstanding.
|
|
2
|
Total returns do not include account service fees that may have applied in the periods shown. Fund prospectuses provide information about any applicable account service fees.
|
|
3
|
Includes performance-based investment advisory fee increases (decreases) of 0.04%, 0.05%, 0.05%, 0.05%, 0.06%, and 0.02%.
|
|
4
|
The ratio of expenses to average net assets for the period net of reduction from broker commission abatement arrangements was 0.44% and 0.45%, respectively.
|
|
5
|
The ratio of expenses to average net assets for the period net of reduction from custody fee offset and broker commission abatement arrangements was 0.45%, 0.44% and 0.46% respectively.
|
|
Admiral Shares
|
|
|
|
|
|
|
|
For a Share Outstanding
Throughout Each Period
|
Six Months
Ended
July 31,
2026
|
Year Ended January 31,
|
||||
|
2026
|
2025
|
2024
|
2023
|
2022
|
||
|
Net Asset Value, Beginning of Period
|
$100.66
|
$82.62
|
$84.83
|
$87.12
|
$78.12
|
$59.39
|
|
Investment Operations
|
||||||
|
Net Investment Income1
|
1.750
|
3.156
|
3.392
|
3.599
|
4.014
|
2.615
|
|
Net Realized and Unrealized Gain (Loss) on Investments
|
12.579
|
19.345
|
9.886
|
.145
|
9.026
|
18.794
|
|
Total from Investment Operations
|
14.329
|
22.501
|
13.278
|
3.744
|
13.040
|
21.409
|
|
Distributions
|
||||||
|
Dividends from Net Investment Income
|
-
|
(3.246)
|
(3.238)
|
(3.733)
|
(4.040)
|
(2.679)
|
|
Distributions from Realized Capital Gains
|
(3.419)
|
(1.215)
|
(12.250)
|
(2.301)
|
-
|
-
|
|
Total Distributions
|
(3.419)
|
(4.461)
|
(15.488)
|
(6.034)
|
(4.040)
|
(2.679)
|
|
Net Asset Value, End of Period
|
$111.57
|
$100.66
|
$82.62
|
$84.83
|
$87.12
|
$78.12
|
|
Total Return2
|
14.22%
|
27.70%
|
16.33%
|
4.09%
|
16.83%
|
36.43%
|
|
Ratios/Supplemental Data
|
|
|
|
|
|
|
|
Net Assets, End of Period (Millions)
|
$5,371
|
$4,677
|
$3,767
|
$3,625
|
$4,176
|
$3,608
|
|
Ratio of Total Expenses to Average Net Assets3
|
0.36%4
|
0.37%4
|
0.37%5
|
0.36%5
|
0.38%5
|
0.33%
|
|
Ratio of Net Investment Income to Average Net Assets
|
3.22%
|
3.48%
|
3.69%
|
4.11%
|
4.78%
|
3.76%
|
|
Portfolio Turnover Rate
|
8%
|
19%
|
36%
|
29%
|
16%
|
14%
|
|
The expense ratio and net investment income ratio for the current period have been annualized.
|
||||||
|
1
|
Calculated based on average shares outstanding.
|
|
2
|
Total returns do not include account service fees that may have applied in the periods shown. Fund prospectuses provide information about any applicable account service fees.
|
|
3
|
Includes performance-based investment advisory fee increases (decreases) of 0.04%, 0.05%, 0.05%, 0.05%, 0.06%, and 0.02%.
|
|
4
|
The ratio of expenses to average net assets for the period net of reduction from broker commission abatement arrangements was 0.36% and 0.37%, respectively.
|
|
5
|
The ratio of expenses to average net assets for the period net of reduction from custody fee offset and broker commission abatement arrangements was 0.37%, 0.36%, and 0.38% respectively.
|
|
|
Level 1
($000)
|
Level 2
($000)
|
Level 3
($000)
|
Total
($000)
|
|
Investments
|
|
|
|
|
|
Assets
|
|
|
|
|
|
Common Stocks-North and South America
|
4,717,013
|
-
|
-
|
4,717,013
|
|
Common Stocks-Other
|
317,750
|
2,241,500
|
-
|
2,559,250
|
|
Temporary Cash Investments
|
59
|
36,600
|
-
|
36,659
|
|
Total
|
5,034,822
|
2,278,100
|
-
|
7,312,922
|
|
|
Amount
($000)
|
|
Tax Cost
|
4,740,542
|
|
Gross Unrealized Appreciation
|
2,666,654
|
|
Gross Unrealized Depreciation
|
(94,274)
|
|
Net Unrealized Appreciation (Depreciation)
|
2,572,380
|
|
|
Six Months Ended
July 31, 2026
|
Year Ended
January 31, 2026
|
||
|
|
Amount
($000)
|
Shares
(000)
|
Amount
($000)
|
Shares
(000)
|
|
Investor Shares
|
||||
|
Issued
|
230,111
|
3,946
|
245,956
|
5,073
|
|
Issued in Lieu of Cash Distributions
|
63,230
|
1,058
|
75,412
|
1,526
|
|
Redeemed
|
(508,123)
|
(8,800)
|
(549,428)
|
(11,379)
|
|
Net Increase (Decrease)-Investor Shares
|
(214,782)
|
(3,796)
|
(228,060)
|
(4,780)
|
|
Admiral Shares
|
||||
|
Issued
|
597,929
|
5,506
|
598,680
|
6,585
|
|
Issued in Lieu of Cash Distributions
|
143,354
|
1,279
|
178,110
|
1,921
|
|
Redeemed
|
(557,590)
|
(5,106)
|
(690,084)
|
(7,644)
|
|
Net Increase (Decrease)-Admiral Shares
|
183,693
|
1,679
|
86,706
|
862
|
|
Financial Statements
|
1
|
|
|
|
|
|
|
Shares
|
Market
Value•
($000)
|
|
Common Stocks (97.8%)
|
|||
|
Belgium (3.4%)
|
|||
|
|
UCB SA
|
2,513,004
|
645,046
|
|
*
|
Argenx SE
|
749,701
|
642,117
|
|
|
|
|
1,287,163
|
|
China (0.8%)
|
|||
|
|
Jiangsu Hengrui Pharmaceuticals Co. Ltd. Class H
|
9,939,973
|
72,450
|
|
*
|
Zai Lab Ltd.
|
36,431,700
|
66,385
|
|
*,1
|
GenFleet Therapeutics Shanghai Inc. Class H
|
18,491,938
|
65,325
|
|
*
|
Duality Biotherapeutics Inc.
|
2,771,377
|
64,436
|
|
|
Shandong Weigao Group Medical Polymer Co. Ltd. Class H
|
77,092,000
|
33,001
|
|
|
|
|
301,597
|
|
Denmark (2.2%)
|
|||
|
*
|
Genmab A/S
|
1,278,865
|
368,107
|
|
*
|
Ascendis Pharma A/S
|
1,099,854
|
268,265
|
|
|
Novo Nordisk A/S Class B
|
4,140,939
|
195,873
|
|
|
|
|
832,245
|
|
Japan (4.7%)
|
|||
|
|
Shionogi & Co. Ltd.
|
21,427,449
|
387,436
|
|
|
Otsuka Holdings Co. Ltd.
|
5,423,000
|
376,028
|
|
|
Daiichi Sankyo Co. Ltd.
|
22,675,166
|
366,465
|
|
|
Chugai Pharmaceutical Co. Ltd.
|
8,264,744
|
358,618
|
|
|
Eisai Co. Ltd.
|
7,339,417
|
220,644
|
|
|
M3 Inc.
|
9,451,653
|
105,888
|
|
|
|
|
1,815,079
|
|
Netherlands (0.1%)
|
|||
|
*
|
Pharvaris NV
|
1,165,414
|
38,016
|
|
Switzerland (4.5%)
|
|||
|
|
Novartis AG (Registered)
|
4,658,547
|
728,558
|
|
|
Galderma Group AG
|
2,410,425
|
524,536
|
|
|
Roche Holding AG
|
1,029,839
|
450,135
|
|
|
|
|
1,703,229
|
|
United Kingdom (8.0%)
|
|||
|
|
AstraZeneca plc
|
10,300,505
|
1,752,222
|
|
|
GSK plc
|
44,047,406
|
1,145,358
|
|
*,1
|
Immunocore Holdings plc ADR
|
4,246,274
|
143,567
|
|
|
|
|
3,041,147
|
|
United States (74.1%)
|
|||
|
|
Eli Lilly & Co.
|
2,861,509
|
3,287,416
|
|
|
Merck & Co. Inc.
|
15,657,269
|
2,038,576
|
|
|
Johnson & Johnson
|
7,191,566
|
1,843,558
|
|
|
UnitedHealth Group Inc.
|
3,730,515
|
1,545,925
|
|
*
|
Edwards Lifesciences Corp.
|
11,357,910
|
977,575
|
|
*
|
Intuitive Surgical Inc.
|
2,725,449
|
962,983
|
|
|
CVS Health Corp.
|
9,210,092
|
961,810
|
|
|
Cencora Inc.
|
3,033,825
|
944,551
|
|
*
|
Vertex Pharmaceuticals Inc.
|
1,890,142
|
901,787
|
|
|
AbbVie Inc.
|
3,506,192
|
879,844
|
|
|
Danaher Corp.
|
4,275,150
|
833,569
|
|
|
Regeneron Pharmaceuticals Inc.
|
1,072,221
|
817,708
|
|
|
Elevance Health Inc. (XNYS)
|
1,858,361
|
698,446
|
|
|
HCA Healthcare Inc.
|
1,594,006
|
641,731
|
|
*
|
Boston Scientific Corp.
|
13,314,532
|
622,188
|
|
|
Agilent Technologies Inc.
|
4,119,810
|
570,058
|
|
*
|
Biogen Inc.
|
2,745,486
|
557,196
|
|
*
|
Alnylam Pharmaceuticals Inc.
|
2,136,580
|
439,110
|
|
*
|
Dexcom Inc.
|
5,155,320
|
430,211
|
|
|
Cardinal Health Inc.
|
1,736,348
|
399,412
|
|
|
|
Shares
|
Market
Value•
($000)
|
|
|
Abbott Laboratories
|
3,719,444
|
393,145
|
|
*
|
Centene Corp.
|
6,149,030
|
382,593
|
|
|
Amgen Inc.
|
984,663
|
379,253
|
|
*
|
Revolution Medicines Inc.
|
1,988,729
|
372,946
|
|
*
|
United Therapeutics Corp.
|
719,385
|
372,433
|
|
|
Medtronic plc
|
4,228,128
|
361,040
|
|
|
Stryker Corp.
|
1,087,087
|
354,064
|
|
*
|
Ionis Pharmaceuticals Inc.
|
6,212,640
|
321,628
|
|
*
|
Incyte Corp.
|
2,386,201
|
285,199
|
|
|
Thermo Fisher Scientific Inc.
|
458,983
|
263,594
|
|
*
|
Madrigal Pharmaceuticals Inc.
|
563,117
|
263,156
|
|
*
|
Cytokinetics Inc.
|
3,341,262
|
257,712
|
|
*
|
Bridgebio Pharma Inc.
|
3,162,851
|
253,313
|
|
|
STERIS plc
|
1,100,961
|
251,460
|
|
|
QIAGEN NV
|
6,045,368
|
250,278
|
|
*
|
CG oncology Inc.
|
2,860,428
|
203,634
|
|
|
Bristol-Myers Squibb Co.
|
3,063,693
|
200,090
|
|
*
|
PTC Therapeutics Inc.
|
2,865,974
|
194,915
|
|
*
|
Kymera Therapeutics Inc.
|
1,796,469
|
185,755
|
|
*
|
Scholar Rock Holding Corp.
|
3,859,866
|
182,552
|
|
*
|
Protagonist Therapeutics Inc.
|
1,243,618
|
169,928
|
|
*
|
Dianthus Therapeutics Inc.
|
1,503,955
|
160,803
|
|
*
|
Structure Therapeutics Inc. ADR
|
3,278,237
|
157,487
|
|
*
|
ICON plc
|
933,744
|
152,728
|
|
*
|
Option Care Health Inc.
|
6,456,359
|
148,690
|
|
*,1
|
HeartFlow Inc.
|
5,795,579
|
146,222
|
|
*
|
Celldex Therapeutics Inc.
|
3,783,994
|
144,019
|
|
|
Encompass Health Corp.
|
1,252,498
|
139,115
|
|
*
|
Moderna Inc.
|
2,345,644
|
128,588
|
|
*
|
Vaxcyte Inc.
|
2,340,735
|
126,587
|
|
*
|
Alignment Healthcare Inc.
|
8,232,279
|
122,249
|
|
*,1
|
Inspire Medical Systems Inc.
|
2,093,826
|
105,131
|
|
*
|
Arcus Biosciences Inc.
|
3,445,827
|
97,138
|
|
*,2
|
Zenas Biopharma Inc.
|
2,937,055
|
92,341
|
|
*
|
Immunome Inc.
|
3,703,461
|
84,291
|
|
*
|
Dyne Therapeutics Inc.
|
2,808,140
|
70,709
|
|
*
|
Stoke Therapeutics Inc.
|
2,260,550
|
65,239
|
|
*,2
|
Kailera Therapeutics Inc.
|
2,191,928
|
37,131
|
|
*,2
|
Aktis Oncology Inc.
|
1,462,244
|
32,272
|
|
*
|
Definium Therapeutics Inc.
|
740,600
|
32,231
|
|
|
|
|
28,295,313
|
|
Total Common Stocks (Cost $22,967,911)
|
37,313,789
|
||
|
Temporary Cash Investments (2.3%)
|
|||
|
Money Market Fund (0.1%)
|
|||
|
3,4
|
Vanguard Market Liquidity Fund, 3.718%
|
546,991
|
54,694
|
|
|
|
Face
Amount
($000)
|
|
|
Repurchase Agreements (2.2%)
|
|||
|
|
Bank of America Securities, LLC, 3.650%, 8/3/2026
(Dated 7/31/2026, Repurchase Value $15,005, collateralized by U.S. Treasury Obligations 1.750%-2.750%, 8/15/2041-8/15/2051, with a
value of $15,300)
|
15,000
|
15,000
|
|
|
Bank of America Securities, LLC, 3.650%, 8/3/2026
(Dated 7/31/2026, Repurchase Value $18,906, collateralized by U.S. Government Agency Obligations 3.000%-5.084%,
11/1/2046-8/1/2056, with a value of $19,278)
|
18,900
|
18,900
|
|
|
Bank of America Securities, LLC, 3.660%, 8/3/2026
(Dated 7/31/2026, Repurchase Value $40,012, collateralized by U.S. Government Agency Obligations 2.000%-6.000%,
10/1/2026-7/1/2056, with a value of $40,800)
|
40,000
|
40,000
|
|
|
Bank of Nova Scotia, 3.640%, 8/3/2026
(Dated 7/31/2026, Repurchase Value $63,319, collateralized by U.S. Treasury Obligations 0.000%-4.625%, 9/15/2026-8/15/2043, with a
value of $64,586)
|
63,300
|
63,300
|
|
|
Barclays Capital Inc., 3.640%, 8/3/2026
(Dated 7/31/2026, Repurchase Value $59,118, collateralized by U.S. Treasury Obligations 3.750%, 6/30/2030, with a value of $60,282)
|
59,100
|
59,100
|
|
|
BNP Paribas Securities Corp., 3.640%, 8/3/2026
(Dated 7/31/2026, Repurchase Value $82,425, collateralized by U.S. Treasury Obligations 1.125%-4.625%, 1/31/2027-11/15/2055, with
a value of $84,048)
|
82,400
|
82,400
|
|
|
|
Face
Amount
($000)
|
Market
Value•
($000)
|
|
|
BNP Paribas Securities Corp., 3.650%, 8/3/2026
(Dated 7/31/2026, Repurchase Value $60,618, collateralized by U.S. Government Agency Obligations 1.820%-7.000%,
3/1/2029-6/1/2056, with a value of $61,812)
|
60,600
|
60,600
|
|
|
HSBC Bank USA, 3.640%, 8/3/2026
(Dated 7/31/2026, Repurchase Value $122,737, collateralized by U.S. Treasury Obligations 0.625%-4.250%, 7/31/2028-2/15/2043, with
a value of $125,154)
|
122,700
|
122,700
|
|
|
HSBC Bank USA, 3.650%, 8/3/2026
(Dated 7/31/2026, Repurchase Value $78,524, collateralized by U.S. Government Agency Obligations 2.000%-7.000%,
2/1/2034-6/1/2056, with a value of $80,070)
|
78,500
|
78,500
|
|
|
JP Morgan Securities, LLC, 3.640%, 8/3/2026
(Dated 7/31/2026, Repurchase Value $55,017, collateralized by U.S. Treasury Obligations 0.000%, 10/1/2026, with a value of $56,100)
|
55,000
|
55,000
|
|
|
Natixis SA, 3.640%, 8/3/2026
(Dated 7/31/2026, Repurchase Value $149,845, collateralized by U.S. Treasury and Government Agency Obligations 0.375%-6.250%,
1/31/2027-2/15/2055, with a value of $152,796)
|
149,800
|
149,800
|
|
|
Nomura International plc, 3.640%, 8/3/2026
(Dated 7/31/2026, Repurchase Value $500, collateralized by U.S. Treasury Obligations 0.000%, 12/31/2026, with a value of $511)
|
500
|
500
|
|
|
Nomura International plc, 3.640%, 8/3/2026
(Dated 7/31/2026, Repurchase Value $85,026, collateralized by U.S. Treasury Obligations 1.625%-4.625%, 3/31/2029-5/15/2031, with a
value of $86,700)
|
85,000
|
85,000
|
|
|
|
|
830,800
|
|
Total Temporary Cash Investments (Cost $885,493)
|
885,494
|
||
|
Total Investments (100.1%) (Cost $23,853,404)
|
38,199,283
|
||
|
Other Assets and Liabilities-Net (-0.1%)
|
(33,257)
|
||
|
Net Assets (100%)
|
38,166,026
|
||
|
Cost is in $000.
|
|||
|
•
|
See Note A in Notes to Financial Statements.
|
|
*
|
Non-income-producing security.
|
|
1
|
Considered an affiliated company of the fund as the fund owns more than 5% of the outstanding voting securities of such company.
|
|
2
|
Includes partial security positions on loan to broker-dealers. The total value of securities on loan is $53,202.
|
|
3
|
Affiliated money market fund available only to Vanguard funds and certain trusts and accounts managed by Vanguard. Rate shown is the 7-day yield.
|
|
4
|
Collateral of $54,641 was received for securities on loan.
|
|
|
ADR-American Depositary Receipt.
|
|
|
|
|
($000s, except shares and per-share amounts)
|
Amount
|
|
Assets
|
|
|
Investments in Securities, at Value1
|
|
|
Unaffiliated Issuers (Cost $23,201,321)
|
37,684,344
|
|
Affiliated Issuers (Cost $652,083)
|
514,939
|
|
Total Investments in Securities
|
38,199,283
|
|
Investment in Vanguard
|
831
|
|
Cash
|
48
|
|
Foreign Currency, at Value (Cost $2,775)
|
2,945
|
|
Receivables for Investment Securities Sold
|
102,251
|
|
Receivables for Accrued Income
|
114,621
|
|
Receivables for Capital Shares Issued
|
1,859
|
|
Other Assets
|
45
|
|
Total Assets
|
38,421,883
|
|
Liabilities
|
|
|
Payables for Investment Securities Purchased
|
174,903
|
|
Collateral for Securities on Loan
|
54,641
|
|
Payables to Investment Advisor
|
13,722
|
|
Payables for Capital Shares Redeemed
|
10,257
|
|
Payables to Vanguard
|
2,334
|
|
Total Liabilities
|
255,857
|
|
Net Assets
|
38,166,026
|
|
1 Includes $53,202 of securities on loan.
|
|
|
At July 31, 2026, net assets consisted of:
|
|
|
|
|
|
Paid-in Capital
|
21,283,210
|
|
Total Distributable Earnings (Loss)
|
16,882,816
|
|
Net Assets
|
38,166,026
|
|
|
|
|
Investor Shares-Net Assets
|
|
|
Applicable to 26,330,964 outstanding $.001 par value shares of
beneficial interest (unlimited authorization)
|
5,348,633
|
|
Net Asset Value Per Share-Investor Shares
|
$203.13
|
|
|
|
|
Admiral™ Shares-Net Assets
|
|
|
Applicable to 383,131,007 outstanding $.001 par value shares of
beneficial interest (unlimited authorization)
|
32,817,393
|
|
Net Asset Value Per Share-Admiral Shares
|
$85.66
|
|
|
|
|
|
Six Months Ended
July 31, 2026
|
|
|
($000)
|
|
Investment Income
|
|
|
Income
|
|
|
Dividends-Unaffiliated Issuers1
|
247,103
|
|
Interest-Unaffiliated Issuers
|
11,460
|
|
Securities Lending-Net
|
126
|
|
Total Income
|
258,689
|
|
Expenses
|
|
|
Investment Advisory Fees-Note B
|
|
|
Basic Fee
|
27,497
|
|
Performance Adjustment
|
1,498
|
|
The Vanguard Group-Note C
|
|
|
Management and Administrative-Investor Shares
|
4,878
|
|
Management and Administrative-Admiral Shares
|
20,143
|
|
Marketing and Distribution-Investor Shares
|
137
|
|
Marketing and Distribution-Admiral Shares
|
426
|
|
Custodian Fees
|
217
|
|
Shareholders' Reports-Investor Shares
|
60
|
|
Shareholders' Reports-Admiral Shares
|
63
|
|
Trustees' Fees and Expenses
|
9
|
|
Other Expenses
|
129
|
|
Total Expenses
|
55,057
|
|
Expenses Paid Indirectly
|
(10
)
|
|
Net Expenses
|
55,047
|
|
Net Investment Income
|
203,642
|
|
Realized Net Gain (Loss)
|
|
|
Investment Securities Sold-Unaffiliated Issuers
|
2,351,725
|
|
Investment Securities Sold-Affiliated Issuers
|
37,673
|
|
Foreign Currencies
|
(1,214
)
|
|
Realized Net Gain (Loss)
|
2,388,184
|
|
Change in Unrealized Appreciation (Depreciation)
|
|
|
Investment Securities-Unaffiliated Issuers
|
(1,615,938
)
|
|
Investment Securities-Affiliated Issuers
|
249,313
|
|
Foreign Currencies
|
(3,844
)
|
|
Change in Unrealized Appreciation (Depreciation)
|
(1,370,469
)
|
|
Net Increase (Decrease) in Net Assets Resulting from Operations
|
1,221,357
|
|
1
|
Dividends are net of foreign withholding taxes of $8,894.
|
|
|
||
|
|
Six Months Ended
July 31,
2026
|
Year Ended
January 31,
2026
|
|
|
($000)
|
($000)
|
|
Increase (Decrease) in Net Assets
|
||
|
Operations
|
||
|
Net Investment Income
|
203,642
|
450,050
|
|
Realized Net Gain (Loss)
|
2,388,184
|
2,133,114
|
|
Change in Unrealized Appreciation (Depreciation)
|
(1,370,469
)
|
1,258,174
|
|
Net Increase (Decrease) in Net Assets Resulting from Operations
|
1,221,357
|
3,841,338
|
|
Distributions
|
||
|
Investor Shares
|
(211,056
)
|
(261,878
)
|
|
Admiral Shares
|
(1,241,675
)
|
(1,510,572
)
|
|
Total Distributions
|
(1,452,731
)
|
(1,772,450
)
|
|
Capital Share Transactions
|
||
|
Investor Shares
|
(351,353
)
|
(964,124
)
|
|
Admiral Shares
|
(515,065
)
|
(3,747,907
)
|
|
Net Increase (Decrease) from Capital Share Transactions
|
(866,418
)
|
(4,712,031
)
|
|
Total Increase (Decrease)
|
(1,097,792
)
|
(2,643,143
)
|
|
Net Assets
|
||
|
Beginning of Period
|
39,263,818
|
41,906,961
|
|
End of Period
|
38,166,026
|
39,263,818
|
|
Investor Shares
|
|
|
|
|
|
|
|
For a Share Outstanding
Throughout Each Period
|
Six Months
Ended
July 31,
2026
|
Year Ended January 31,
|
||||
|
2026
|
2025
|
2024
|
2023
|
2022
|
||
|
Net Asset Value, Beginning of Period
|
$204.68
|
$192.16
|
$210.61
|
$212.59
|
$210.54
|
$218.60
|
|
Investment Operations
|
||||||
|
Net Investment Income1
|
1.019
|
2.125
|
1.733
|
1.789
|
1.654
|
1.869
|
|
Net Realized and Unrealized Gain (Loss) on Investments
|
5.089
|
19.194
|
3.617
|
11.217
|
11.988
|
8.949
|
|
Total from Investment Operations
|
6.108
|
21.319
|
5.350
|
13.006
|
13.642
|
10.818
|
|
Distributions
|
||||||
|
Dividends from Net Investment Income
|
(.136)
|
(2.117)
|
(1.809)
|
(1.751)
|
(1.659)
|
(1.951)
|
|
Distributions from Realized Capital Gains
|
(7.522)
|
(6.682)
|
(21.991)
|
(13.235)
|
(9.933)
|
(16.927)
|
|
Total Distributions
|
(7.658)
|
(8.799)
|
(23.800)
|
(14.986)
|
(11.592)
|
(18.878)
|
|
Net Asset Value, End of Period
|
$203.13
|
$204.68
|
$192.16
|
$210.61
|
$212.59
|
$210.54
|
|
Total Return2
|
3.35%
|
11.39%
|
2.96%
|
6.43%
|
6.57%
|
4.48%
|
|
Ratios/Supplemental Data
|
|
|
|
|
|
|
|
Net Assets, End of Period (Millions)
|
$5,349
|
$5,749
|
$6,428
|
$7,297
|
$7,496
|
$7,493
|
|
Ratio of Total Expenses to Average Net Assets3
|
0.34%4
|
0.33%4
|
0.37%5
|
0.35%5
|
0.34%5
|
0.30%
|
|
Ratio of Net Investment Income to Average Net Assets
|
1.04%
|
1.15%
|
0.81%
|
0.86%
|
0.80%
|
0.82%
|
|
Portfolio Turnover Rate
|
24%
|
47%
|
29%
|
16%
|
19%
|
15%
|
|
The expense ratio and net investment income ratio for the current period have been annualized.
|
||||||
|
1
|
Calculated based on average shares outstanding.
|
|
2
|
Total returns do not include account service fees that may have applied in the periods shown. Fund prospectuses provide information about any applicable account service fees.
|
|
3
|
Includes performance-based investment advisory fee increases (decreases) of 0.01%, (0.01%), 0.04%, 0.02%, 0.00%, and (0.04%).
|
|
4
|
The ratio of expenses to average net assets for the period net of reduction from broker commission abatement arrangements was 0.34%, and 0.33% respectively.
|
|
5
|
The ratio of expenses to average net assets for the period net of reduction from custody fee offset and broker commission abatement arrangements was 0.37%, 0.35% and 0.34% respectively.
|
|
Admiral Shares
|
|
|
|
|
|
|
|
For a Share Outstanding
Throughout Each Period
|
Six Months
Ended
July 31,
2026
|
Year Ended January 31,
|
||||
|
2026
|
2025
|
2024
|
2023
|
2022
|
||
|
Net Asset Value, Beginning of Period
|
$86.30
|
$81.02
|
$88.81
|
$89.64
|
$88.77
|
$92.17
|
|
Investment Operations
|
||||||
|
Net Investment Income1
|
.453
|
.940
|
.772
|
.796
|
.750
|
.830
|
|
Net Realized and Unrealized Gain (Loss) on Investments
|
2.150
|
8.099
|
1.523
|
4.738
|
5.052
|
3.780
|
|
Total from Investment Operations
|
2.603
|
9.039
|
2.295
|
5.534
|
5.802
|
4.610
|
|
Distributions
|
||||||
|
Dividends from Net Investment Income
|
(.072)
|
(.941)
|
(.810)
|
(.782)
|
(.743)
|
(.870)
|
|
Distributions from Realized Capital Gains
|
(3.171)
|
(2.818)
|
(9.275)
|
(5.582)
|
(4.189)
|
(7.140)
|
|
Total Distributions
|
(3.243)
|
(3.759)
|
(10.085)
|
(6.364)
|
(4.932)
|
(8.010)
|
|
Net Asset Value, End of Period
|
$85.66
|
$86.30
|
$81.02
|
$88.81
|
$89.64
|
$88.77
|
|
Total Return2
|
3.38%
|
11.46%
|
3.01%
|
6.48%
|
6.63%
|
4.53%
|
|
Ratios/Supplemental Data
|
|
|
|
|
|
|
|
Net Assets, End of Period (Millions)
|
$32,817
|
$33,515
|
$35,479
|
$38,997
|
$39,981
|
$39,934
|
|
Ratio of Total Expenses to Average Net Assets3
|
0.28%4
|
0.27%4
|
0.32%5
|
0.30%5
|
0.29%5
|
0.25%
|
|
Ratio of Net Investment Income to Average Net Assets
|
1.09%
|
1.20%
|
0.85%
|
0.90%
|
0.86%
|
0.86%
|
|
Portfolio Turnover Rate
|
24%
|
47%
|
29%
|
16%
|
19%
|
15%
|
|
The expense ratio and net investment income ratio for the current period have been annualized.
|
||||||
|
1
|
Calculated based on average shares outstanding.
|
|
2
|
Total returns do not include account service fees that may have applied in the periods shown. Fund prospectuses provide information about any applicable account service fees.
|
|
3
|
Includes performance-based investment advisory fee increases (decreases) of 0.01%, (0.01%), 0.04%, 0.02%, 0.00%, and (0.04%).
|
|
4
|
The ratio of expenses to average net assets for the period net of reduction from broker commission abatement arrangements was 0.28%, and 0.27% respectively.
|
|
5
|
The ratio of expenses to average net assets for the period net of reduction from custody fee offset and broker commission abatement arrangements was 0.32%, 0.30%, and 0.29% respectively.
|
|
|
Level 1
($000)
|
Level 2
($000)
|
Level 3
($000)
|
Total
($000)
|
|
Investments
|
|
|
|
|
|
Assets
|
|
|
|
|
|
Common Stocks-North and South America
|
28,295,313
|
-
|
-
|
28,295,313
|
|
Common Stocks-Other
|
449,848
|
8,568,628
|
-
|
9,018,476
|
|
Temporary Cash Investments
|
54,694
|
830,800
|
-
|
885,494
|
|
Total
|
28,799,855
|
9,399,428
|
-
|
38,199,283
|
|
|
Amount
($000)
|
|
Tax Cost
|
24,032,707
|
|
Gross Unrealized Appreciation
|
15,117,326
|
|
Gross Unrealized Depreciation
|
(950,750)
|
|
Net Unrealized Appreciation (Depreciation)
|
14,166,576
|
|
|
Six Months Ended
July 31, 2026
|
Year Ended
January 31, 2026
|
||
|
|
Amount
($000)
|
Shares
(000)
|
Amount
($000)
|
Shares
(000)
|
|
Investor Shares
|
||||
|
Issued
|
72,802
|
368
|
263,438
|
1,377
|
|
Issued in Lieu of Cash Distributions
|
198,557
|
1,074
|
246,441
|
1,274
|
|
Redeemed
|
(622,712)
|
(3,199)
|
(1,474,003)
|
(8,017)
|
|
Net Increase (Decrease)-Investor Shares
|
(351,353)
|
(1,757)
|
(964,124)
|
(5,366)
|
|
Admiral Shares
|
||||
|
Issued
|
348,487
|
4,280
|
667,798
|
8,521
|
|
Issued in Lieu of Cash Distributions
|
1,071,689
|
13,755
|
1,309,382
|
16,039
|
|
Redeemed
|
(1,935,241)
|
(23,267)
|
(5,725,087)
|
(74,113)
|
|
Net Increase (Decrease)-Admiral Shares
|
(515,065)
|
(5,232)
|
(3,747,907)
|
(49,553)
|
|
|
|
Current Period Transactions
|
|
|||||
|
|
Jan. 31,
2026
Market
Value
($000)
|
Purchases
at Cost
($000)
|
Proceeds
from
Securities
Sold
($000)
|
Realized
Net
Gain
(Loss)
($000)
|
Change in
Unrealized
App. (Dep.)
($000)
|
Income
($000)
|
Capital Gain
Distributions
Received
($000)
|
Jul. 31,
2026
Market
Value
($000)
|
|
Acadia Healthcare Co. Inc.
|
118,483
|
-
|
241,515
|
(141,271
)
|
264,303
|
-
|
-
|
-
|
|
Apellis Pharmaceuticals Inc.
|
172,343
|
18,957
|
350,318
|
171,666
|
(12,648
)
|
-
|
-
|
-
|
|
Celldex Therapeutics Inc.
|
117,212
|
2,428
|
36,000
|
9,127
|
51,252
|
-
|
-
|
NA1
|
|
GenFleet Therapeutics Shanghai Inc. Class H
|
NA2
|
60,436
|
-
|
-
|
(2,904
)
|
-
|
-
|
65,325
|
|
HeartFlow Inc.
|
NA2
|
116,431
|
17,559
|
(1,848
)
|
(18,205
)
|
-
|
-
|
146,222
|
|
Immunocore Holdings plc ADR
|
119,062
|
18,716
|
-
|
-
|
5,789
|
-
|
-
|
143,567
|
|
Inspire Medical Systems Inc.
|
NA2
|
60,500
|
-
|
-
|
(38,274
)
|
-
|
-
|
105,131
|
|
Vanguard Market Liquidity Fund
|
58,780
|
NA3
|
NA3
|
(1
)
|
-
|
-
|
-
|
54,694
|
|
Total
|
585,880
|
277,468
|
645,392
|
37,673
|
249,313
|
-
|
-
|
514,939
|
|
1
|
Not applicable-at July 31, 2026, the issuer was not an affiliated company of the fund.
|
|
2
|
Not applicable-at January 31, 2026, the issuer was not an affiliated company of the fund.
|
|
3
|
Not applicable-purchases and sales are for temporary cash investment purposes.
|
|
Financial Statements
|
1
|
|
|
|
|
|
|
Shares
|
Market
Value•
($000)
|
|
Common Stocks (99.6%)
|
|||
|
Consumer Discretionary (4.2%)
|
|||
|
|
Home Depot Inc.
|
5,635,483
|
1,870,755
|
|
|
McDonald's Corp.
|
4,020,007
|
1,087,975
|
|
|
Starbucks Corp.
|
6,448,365
|
678,690
|
|
|
Lowe's Cos. Inc.
|
3,168,810
|
658,510
|
|
|
NIKE Inc. Class B
|
6,786,699
|
283,073
|
|
|
DR Horton Inc.
|
1,492,167
|
213,469
|
|
|
Williams-Sonoma Inc.
|
666,181
|
152,329
|
|
|
Tractor Supply Co.
|
2,967,328
|
91,305
|
|
|
Dick's Sporting Goods Inc.
|
372,736
|
73,023
|
|
|
Service Corp. International
|
780,632
|
67,283
|
|
|
Domino's Pizza Inc.
|
173,140
|
60,156
|
|
|
Lithia Motors Inc.
|
129,037
|
49,733
|
|
|
Pool Corp.
|
181,450
|
33,697
|
|
|
Churchill Downs Inc.
|
374,632
|
31,581
|
|
|
Brunswick Corp.
|
367,639
|
29,044
|
|
|
Graham Holdings Co. Class B
|
18,918
|
22,769
|
|
|
Thor Industries Inc.
|
297,629
|
22,313
|
|
|
Dillard's Inc. Class A
|
17,106
|
10,064
|
|
|
Shoe Station Group Inc.
|
101,061
|
1,536
|
|
|
|
|
5,437,305
|
|
Consumer Staples (9.3%)
|
|||
|
|
Walmart Inc.
|
24,804,699
|
2,758,282
|
|
|
Costco Wholesale Corp.
|
2,510,169
|
2,389,405
|
|
|
Coca-Cola Co.
|
21,908,953
|
1,919,005
|
|
|
Procter & Gamble Co.
|
13,175,110
|
1,903,672
|
|
|
PepsiCo Inc.
|
7,733,128
|
1,079,235
|
|
|
Mondelez International Inc. Class A
|
7,262,857
|
452,549
|
|
|
Colgate-Palmolive Co.
|
4,527,448
|
413,356
|
|
|
Sysco Corp.
|
2,705,553
|
230,621
|
|
|
Archer-Daniels-Midland Co.
|
2,726,900
|
216,161
|
|
|
Casey's General Stores Inc.
|
209,118
|
182,142
|
|
|
Church & Dwight Co. Inc.
|
1,340,643
|
132,469
|
|
|
Kroger Co.
|
2,209,425
|
127,572
|
|
|
Constellation Brands Inc. Class A
|
789,072
|
102,761
|
|
|
Tyson Foods Inc. Class A
|
1,596,232
|
92,518
|
|
|
McCormick & Co. Inc.
|
1,437,065
|
73,147
|
|
|
Ingredion Inc.
|
356,787
|
35,486
|
|
|
Brown-Forman Corp. Class B
|
1,020,870
|
29,330
|
|
|
WD-40 Co.
|
76,102
|
17,286
|
|
|
Andersons Inc.
|
190,829
|
13,507
|
|
|
Marzetti Co.
|
114,776
|
12,266
|
|
|
Brown-Forman Corp. Class A
|
246,899
|
7,214
|
|
|
Oil-Dri Corp. of America
|
57,966
|
5,751
|
|
|
Tootsie Roll Industries Inc.
|
114,541
|
4,469
|
|
|
|
|
12,198,204
|
|
Energy (3.3%)
|
|||
|
|
ExxonMobil Holdings Corp.
|
23,451,892
|
3,645,362
|
|
|
Phillips 66
|
2,268,474
|
480,191
|
|
|
Texas Pacific Land Corp.
|
327,812
|
131,970
|
|
|
DT Midstream Inc.
|
577,186
|
79,652
|
|
|
|
|
4,337,175
|
|
Financials (21.8%)
|
|||
|
|
JPMorgan Chase & Co. (XNYS)
|
15,160,531
|
5,333,323
|
|
|
Visa Inc. Class A (XNYS)
|
8,745,550
|
3,202,008
|
|
|
Mastercard Inc. Class A
|
4,565,250
|
2,616,345
|
|
|
Bank of America Corp. (XNYS)
|
36,939,952
|
2,288,430
|
|
|
Goldman Sachs Group Inc. (XNYS)
|
1,587,953
|
1,617,140
|
|
|
Morgan Stanley
|
6,782,381
|
1,427,149
|
|
|
|
Shares
|
Market
Value•
($000)
|
|
|
Blackrock Inc.
|
816,820
|
890,652
|
|
|
Chubb Ltd.
|
2,040,872
|
715,693
|
|
|
S&P Global Inc.
|
1,715,485
|
706,660
|
|
|
Bank of New York Mellon Corp.
|
3,883,487
|
607,105
|
|
|
CME Group Inc.
|
2,050,196
|
549,022
|
|
|
PNC Financial Services Group Inc.
|
2,193,847
|
548,177
|
|
|
Marsh & McLennan Cos. Inc.
|
2,725,977
|
517,091
|
|
|
Intercontinental Exchange Inc.
|
3,199,633
|
487,880
|
|
|
Travelers Cos. Inc.
|
1,203,132
|
450,404
|
|
|
Aon plc Class A (XNYS)
|
1,208,405
|
435,690
|
|
|
Moody's Corp.
|
850,062
|
406,653
|
|
|
Allstate Corp.
|
1,456,479
|
384,627
|
|
|
Arthur J Gallagher & Co.
|
1,453,523
|
362,538
|
|
|
Aflac Inc.
|
2,591,821
|
330,405
|
|
|
MetLife Inc.
|
3,058,044
|
293,970
|
|
|
Fifth Third Bancorp
|
5,127,894
|
289,726
|
|
|
State Street Corp.
|
1,565,937
|
288,383
|
|
|
Ameriprise Financial Inc.
|
508,629
|
277,630
|
|
|
Nasdaq Inc.
|
2,527,847
|
238,098
|
|
|
MSCI Inc.
|
411,900
|
235,706
|
|
|
Hartford Insurance Group Inc.
|
1,551,020
|
220,105
|
|
|
Cboe Global Markets Inc.
|
592,127
|
183,696
|
|
|
Raymond James Financial Inc.
|
932,874
|
164,167
|
|
|
Cincinnati Financial Corp.
|
875,211
|
155,507
|
|
|
Principal Financial Group Inc.
|
1,112,190
|
126,456
|
|
|
W R Berkley Corp.
|
1,664,001
|
120,707
|
|
|
Brown & Brown Inc.
|
1,649,263
|
116,108
|
|
|
Reinsurance Group of America Inc.
|
370,668
|
87,793
|
|
|
Globe Life Inc.
|
439,309
|
80,064
|
|
|
Assurant Inc.
|
280,342
|
78,269
|
|
|
RenaissanceRe Holdings Ltd.
|
241,217
|
77,185
|
|
|
Unum Group
|
831,683
|
71,616
|
|
|
Evercore Inc. Class A
|
218,860
|
70,158
|
|
|
Jack Henry & Associates Inc.
|
402,008
|
61,925
|
|
|
Wintrust Financial Corp.
|
381,626
|
60,885
|
|
|
Cullen / Frost Bankers Inc.
|
355,312
|
59,103
|
|
|
UMB Financial Corp.
|
404,099
|
58,889
|
|
|
Southstate Bank Corp.
|
552,625
|
58,075
|
|
|
Zions Bancorp NA
|
832,263
|
58,009
|
|
|
Primerica Inc.
|
176,436
|
56,452
|
|
|
American Financial Group Inc.
|
390,182
|
55,297
|
|
|
Old Republic International Corp.
|
1,267,785
|
54,781
|
|
|
FactSet Research Systems Inc.
|
206,121
|
54,251
|
|
|
SEI Investments Co.
|
517,183
|
53,259
|
|
|
Prosperity Bancshares Inc.
|
666,613
|
49,909
|
|
|
Hanover Insurance Group Inc.
|
197,954
|
46,050
|
|
|
Commerce Bancshares Inc.
|
767,095
|
45,466
|
|
|
First American Financial Corp.
|
576,542
|
43,235
|
|
|
Houlihan Lokey Inc.
|
306,771
|
38,497
|
|
|
Erie Indemnity Co. Class A
|
143,742
|
34,791
|
|
|
Home BancShares Inc.
|
1,059,885
|
32,931
|
|
|
MarketAxess Holdings Inc.
|
201,100
|
32,638
|
|
|
Selective Insurance Group Inc.
|
338,745
|
32,110
|
|
|
RLI Corp.
|
520,201
|
31,857
|
|
|
CNO Financial Group Inc.
|
528,197
|
29,098
|
|
|
First Financial Bankshares Inc.
|
737,806
|
25,926
|
|
|
ServisFirst Bancshares Inc.
|
284,568
|
25,469
|
|
|
Morningstar Inc.
|
124,816
|
24,036
|
|
|
United Community Banks Inc.
|
677,281
|
24,003
|
|
|
International Bancshares Corp.
|
306,121
|
23,430
|
|
|
Independent Bank Corp. (XNGS)
|
273,463
|
22,924
|
|
|
Assured Guaranty Ltd.
|
235,439
|
19,475
|
|
|
Community Financial System Inc.
|
297,416
|
19,275
|
|
|
Towne Bank
|
486,216
|
18,432
|
|
|
BOK Financial Corp.
|
120,354
|
17,005
|
|
|
NBT Bancorp Inc.
|
294,165
|
15,488
|
|
|
First Merchants Corp.
|
349,576
|
15,081
|
|
|
Enterprise Financial Services Corp.
|
206,927
|
13,721
|
|
|
BancFirst Corp.
|
117,777
|
13,288
|
|
|
Stock Yards Bancorp Inc.
|
155,250
|
13,212
|
|
|
|
Shares
|
Market
Value•
($000)
|
|
|
Horace Mann Educators Corp.
|
228,394
|
11,902
|
|
|
City Holding Co.
|
79,812
|
11,581
|
|
|
National Bank Holdings Corp. Class A
|
253,337
|
10,942
|
|
|
German American Bancorp Inc.
|
212,453
|
10,810
|
|
|
Nelnet Inc. Class A
|
78,760
|
10,701
|
|
|
TriCo Bancshares
|
180,486
|
10,385
|
|
|
1st Source Corp.
|
102,098
|
9,162
|
|
|
Lakeland Financial Corp.
|
140,911
|
8,828
|
|
|
Bank First Corp.
|
57,458
|
8,776
|
|
|
Westamerica BanCorp
|
132,844
|
7,991
|
|
|
First Mid Bancshares Inc.
|
136,991
|
7,136
|
|
|
Mercantile Bank Corp.
|
97,713
|
5,871
|
|
|
Republic Bancorp Inc. Class A
|
54,402
|
5,415
|
|
|
First Community Bankshares Inc.
|
106,753
|
5,094
|
|
|
Independent Bank Corp.
|
116,599
|
4,454
|
|
|
Capital City Bank Group Inc.
|
78,306
|
4,062
|
|
|
Southern Missouri Bancorp Inc.
|
52,346
|
4,052
|
|
|
Cass Information Systems Inc.
|
64,752
|
3,621
|
|
|
Civista Bancshares Inc.
|
117,595
|
3,417
|
|
|
Northrim BanCorp Inc.
|
125,912
|
3,338
|
|
|
First Business Financial Services Inc.
|
47,305
|
3,321
|
|
|
Home Bancorp Inc.
|
39,080
|
2,788
|
|
|
Unity Bancorp Inc.
|
37,513
|
2,209
|
|
|
Investar Holding Corp.
|
68,648
|
2,068
|
|
|
|
|
28,548,533
|
|
Health Care (17.7%)
|
|||
|
|
Eli Lilly & Co.
|
4,475,796
|
5,141,974
|
|
|
Johnson & Johnson
|
13,619,903
|
3,491,462
|
|
|
AbbVie Inc.
|
9,996,424
|
2,508,503
|
|
|
UnitedHealth Group Inc.
|
5,138,234
|
2,129,284
|
|
|
Merck & Co. Inc.
|
13,974,148
|
1,819,434
|
|
|
Amgen Inc.
|
3,053,644
|
1,176,142
|
|
|
Abbott Laboratories
|
9,855,078
|
1,041,682
|
|
|
Gilead Sciences Inc.
|
7,024,740
|
914,691
|
|
|
Danaher Corp.
|
3,564,034
|
694,915
|
|
|
Stryker Corp.
|
1,952,131
|
635,809
|
|
|
Medtronic plc
|
7,264,159
|
620,287
|
|
|
McKesson Corp.
|
680,107
|
582,301
|
|
|
Elevance Health Inc. (XNYS)
|
1,201,951
|
451,741
|
|
|
Cencora Inc.
|
1,100,813
|
342,727
|
|
|
Cardinal Health Inc.
|
1,325,132
|
304,820
|
|
|
Becton Dickinson & Co.
|
1,558,991
|
258,200
|
|
|
Agilent Technologies Inc.
|
1,598,947
|
221,246
|
|
|
Zoetis Inc.
|
2,371,968
|
183,329
|
|
|
ResMed Inc.
|
820,726
|
173,157
|
|
|
Quest Diagnostics Inc.
|
626,318
|
145,938
|
|
|
West Pharmaceutical Services Inc.
|
399,720
|
136,289
|
|
|
STERIS plc
|
554,901
|
126,739
|
|
|
Ensign Group Inc.
|
327,932
|
58,424
|
|
|
Chemed Corp.
|
75,100
|
39,972
|
|
|
National HealthCare Corp.
|
70,684
|
15,977
|
|
|
LeMaitre Vascular Inc.
|
118,907
|
12,048
|
|
|
|
|
23,227,091
|
|
Industrials (11.9%)
|
|||
|
|
Caterpillar Inc. (XNYS)
|
2,606,004
|
2,123,398
|
|
|
Union Pacific Corp.
|
3,359,190
|
981,320
|
|
|
Eaton Corp. plc
|
2,196,975
|
912,184
|
|
|
Lockheed Martin Corp.
|
1,147,972
|
668,969
|
|
|
Automatic Data Processing Inc.
|
2,261,663
|
602,643
|
|
|
General Dynamics Corp.
|
1,436,113
|
550,634
|
|
|
CSX Corp.
|
10,513,241
|
529,867
|
|
|
Cummins Inc.
|
780,738
|
495,144
|
|
|
Emerson Electric Co.
|
3,169,015
|
474,782
|
|
|
Waste Management Inc.
|
2,090,338
|
473,566
|
|
|
Honeywell International Inc.
|
1,792,588
|
435,689
|
|
|
Illinois Tool Works Inc.
|
1,481,291
|
425,056
|
|
|
Northrop Grumman Corp.
|
755,404
|
409,792
|
|
|
Cintas Corp.
|
1,924,123
|
393,733
|
|
*
|
Honeywell Aerospace Inc.
|
1,792,588
|
370,600
|
|
|
|
Shares
|
Market
Value•
($000)
|
|
|
Comfort Systems USA Inc.
|
198,842
|
343,935
|
|
|
WW Grainger Inc.
|
245,756
|
339,689
|
|
|
Fastenal Co.
|
6,495,538
|
309,902
|
|
|
Rockwell Automation Inc.
|
629,584
|
302,251
|
|
|
L3Harris Technologies Inc.
|
1,054,046
|
292,034
|
|
|
Republic Services Inc.
|
1,131,494
|
238,236
|
|
|
Sunbelt Rentals Holdings Inc.
|
2,321,210
|
166,941
|
|
|
Xylem Inc.
|
1,344,847
|
157,307
|
|
|
Dover Corp.
|
761,907
|
155,901
|
|
|
Hubbell Inc.
|
298,981
|
141,284
|
|
|
Veralto Corp.
|
1,389,581
|
130,857
|
|
|
Expeditors International of Washington Inc.
|
740,010
|
124,240
|
|
|
Snap-on Inc.
|
293,089
|
120,287
|
|
|
RB Global Inc. (XTSE)
|
1,054,076
|
115,674
|
|
|
JB Hunt Transport Services Inc.
|
421,496
|
114,542
|
|
|
HEICO Corp. Class A
|
439,066
|
112,963
|
|
|
Broadridge Financial Solutions Inc.
|
654,383
|
100,742
|
|
|
ITT Inc.
|
505,819
|
99,130
|
|
|
CH Robinson Worldwide Inc.
|
666,913
|
98,523
|
|
|
IDEX Corp.
|
418,772
|
96,506
|
|
|
Nordson Corp.
|
299,846
|
89,288
|
|
|
BWX Technologies Inc.
|
518,356
|
87,447
|
|
|
Carlisle Cos. Inc.
|
228,413
|
82,210
|
|
|
Masco Corp.
|
1,141,390
|
81,587
|
|
1
|
HEICO Corp.
|
227,851
|
81,197
|
|
|
Lincoln Electric Holdings Inc.
|
309,980
|
81,001
|
|
|
Allegion plc
|
486,215
|
76,530
|
|
|
Graco Inc.
|
939,038
|
74,541
|
|
|
Lennox International Inc.
|
179,173
|
74,514
|
|
|
Huntington Ingalls Industries Inc.
|
222,944
|
72,780
|
|
|
Applied Industrial Technologies Inc.
|
209,124
|
72,192
|
|
|
Owens Corning
|
455,622
|
63,286
|
|
|
Donaldson Co. Inc.
|
655,274
|
61,753
|
|
|
Watsco Inc.
|
198,052
|
61,258
|
|
|
Pentair plc
|
914,357
|
59,836
|
|
|
Advanced Drainage Systems Inc.
|
405,477
|
56,150
|
|
|
Ryder System Inc.
|
218,912
|
56,133
|
|
|
Watts Water Technologies Inc. Class A
|
155,452
|
53,754
|
|
|
Toro Co.
|
548,441
|
50,385
|
|
|
Oshkosh Corp.
|
352,777
|
50,239
|
|
|
Timken Co.
|
357,809
|
49,217
|
|
|
Tetra Tech Inc.
|
1,468,390
|
48,692
|
|
|
Booz Allen Hamilton Holding Corp.
|
682,309
|
47,571
|
|
|
Simpson Manufacturing Co. Inc.
|
232,758
|
43,698
|
|
|
MSA Safety Inc.
|
205,312
|
39,065
|
|
|
A O Smith Corp.
|
633,488
|
38,092
|
|
|
Enpro Inc.
|
119,531
|
37,523
|
|
|
GATX Corp.
|
200,857
|
35,927
|
|
*
|
Mobility Global Inc.
|
1,715,482
|
34,962
|
|
|
Matson Inc.
|
171,227
|
34,689
|
|
|
Landstar System Inc.
|
191,967
|
33,550
|
|
|
UFP Industries Inc.
|
319,581
|
27,720
|
|
|
Brady Corp. Class A
|
247,220
|
23,305
|
|
|
Franklin Electric Co. Inc.
|
215,013
|
22,516
|
|
|
Mueller Water Products Inc. Class A
|
885,430
|
22,348
|
|
|
Kadant Inc.
|
66,821
|
20,547
|
|
|
Standex International Corp.
|
68,557
|
20,327
|
|
|
Griffon Corp.
|
218,035
|
18,788
|
|
|
Exponent Inc.
|
274,562
|
18,355
|
|
|
HNI Corp.
|
394,990
|
17,779
|
|
|
McGrath RentCorp.
|
138,933
|
15,998
|
|
|
ABM Industries Inc.
|
331,071
|
15,862
|
|
|
Worthington Enterprises Inc.
|
175,507
|
9,865
|
|
|
Alamo Group Inc.
|
61,255
|
9,744
|
|
|
Gorman-Rupp Co.
|
118,006
|
9,581
|
|
|
Tennant Co.
|
96,373
|
8,098
|
|
|
Lindsay Corp.
|
58,807
|
6,517
|
|
|
Apogee Enterprises Inc.
|
120,061
|
4,754
|
|
|
|
|
15,509,492
|
|
|
|
Shares
|
Market
Value•
($000)
|
|
Information Technology (25.3%)
|
|||
|
|
Broadcom Inc.
|
15,566,653
|
6,059,787
|
|
|
Apple Inc.
|
18,862,838
|
5,826,919
|
|
|
Microsoft Corp.
|
12,220,245
|
5,678,992
|
|
|
Cisco Systems Inc.
|
22,348,281
|
2,592,177
|
|
|
Lam Research Corp.
|
7,075,661
|
2,073,310
|
|
|
Texas Instruments Inc.
|
5,149,253
|
1,419,855
|
|
|
KLA Corp.
|
7,390,866
|
1,351,198
|
|
|
Oracle Corp.
|
9,600,785
|
1,246,854
|
|
|
International Business Machines Corp.
|
5,317,817
|
1,189,330
|
|
|
Amphenol Corp. Class A
|
6,960,596
|
1,118,568
|
|
|
Analog Devices Inc.
|
2,762,229
|
1,014,871
|
|
|
QUALCOMM Inc.
|
5,963,470
|
880,268
|
|
|
Accenture plc Class A
|
3,473,634
|
576,345
|
|
|
Intuit Inc.
|
1,564,701
|
494,555
|
|
|
Motorola Solutions Inc.
|
939,196
|
409,255
|
|
|
TE Connectivity plc
|
1,651,525
|
339,702
|
|
|
Microchip Technology Inc.
|
3,061,711
|
227,455
|
|
|
Roper Technologies Inc.
|
570,981
|
223,807
|
|
|
CDW Corp.
|
722,818
|
106,840
|
|
|
Littelfuse Inc.
|
143,088
|
63,263
|
|
|
Cognex Corp.
|
941,590
|
61,429
|
|
|
Avnet Inc.
|
464,084
|
41,229
|
|
|
Amdocs Ltd.
|
608,646
|
33,914
|
|
|
Badger Meter Inc.
|
165,165
|
22,190
|
|
|
Dolby Laboratories Inc. Class A
|
341,534
|
20,086
|
|
|
Power Integrations Inc.
|
315,298
|
19,142
|
|
|
|
|
33,091,341
|
|
Materials (3.2%)
|
|||
|
|
Linde plc
|
2,615,941
|
1,251,414
|
|
|
Sherwin-Williams Co.
|
1,297,768
|
442,344
|
|
|
Ecolab Inc.
|
1,433,122
|
397,878
|
|
|
Air Products & Chemicals Inc.
|
1,259,923
|
371,539
|
|
|
Nucor Corp.
|
1,288,546
|
331,530
|
|
|
Vulcan Materials Co.
|
734,152
|
197,171
|
|
|
Steel Dynamics Inc.
|
766,991
|
192,714
|
|
|
Martin Marietta Materials Inc.
|
339,743
|
178,413
|
|
|
PPG Industries Inc.
|
1,261,170
|
139,385
|
|
|
Reliance Inc.
|
288,829
|
117,294
|
|
|
Royal Gold Inc.
|
460,965
|
91,432
|
|
|
Albemarle Corp.
|
667,262
|
78,497
|
|
|
RPM International Inc.
|
722,111
|
77,316
|
|
|
Avery Dennison Corp.
|
432,775
|
73,455
|
|
|
Solstice Advanced Materials Inc.
|
898,510
|
54,063
|
|
|
AptarGroup Inc.
|
361,094
|
48,372
|
|
|
Balchem Corp.
|
181,797
|
30,461
|
|
|
Cabot Corp.
|
292,091
|
25,710
|
|
|
Materion Corp.
|
117,694
|
24,815
|
|
|
Silgan Holdings Inc.
|
496,353
|
19,844
|
|
|
Avient Corp.
|
519,005
|
18,850
|
|
|
HB Fuller Co.
|
308,371
|
17,053
|
|
|
Hawkins Inc.
|
118,034
|
15,112
|
|
|
Westlake Corp.
|
188,422
|
13,284
|
|
|
Quaker Chemical Corp.
|
77,600
|
12,456
|
|
|
Innospec Inc.
|
139,314
|
11,978
|
|
|
Stepan Co.
|
122,050
|
7,828
|
|
|
|
|
4,240,208
|
|
Utilities (2.9%)
|
|||
|
|
NextEra Energy Inc.
|
11,798,735
|
1,025,546
|
|
|
American Electric Power Co. Inc.
|
3,078,512
|
393,588
|
|
|
Sempra
|
3,698,536
|
327,505
|
|
|
Entergy Corp.
|
2,590,686
|
278,810
|
|
|
Xcel Energy Inc.
|
3,532,066
|
276,208
|
|
|
Public Service Enterprise Group Inc.
|
2,819,470
|
216,197
|
|
|
Ameren Corp.
|
1,565,855
|
171,633
|
|
|
DTE Energy Co.
|
1,177,011
|
166,983
|
|
|
Atmos Energy Corp.
|
944,417
|
163,176
|
|
|
American Water Works Co. Inc.
|
1,104,881
|
148,242
|
|
|
CMS Energy Corp.
|
1,747,845
|
125,827
|
|
|
|
Shares
|
Market
Value•
($000)
|
|
|
NiSource Inc.
|
2,712,618
|
120,522
|
|
|
Alliant Energy Corp.
|
1,461,303
|
103,431
|
|
|
Essential Utilities Inc.
|
1,604,755
|
63,949
|
|
|
IDACORP Inc.
|
313,490
|
44,801
|
|
|
National Fuel Gas Co.
|
537,705
|
44,258
|
|
|
TXNM Energy Inc.
|
563,742
|
32,652
|
|
|
Otter Tail Corp.
|
237,579
|
21,007
|
|
|
American States Water Co.
|
221,795
|
18,995
|
|
|
Chesapeake Utilities Corp.
|
135,851
|
18,038
|
|
|
MGE Energy Inc.
|
213,626
|
16,990
|
|
|
California Water Service Group
|
338,733
|
16,974
|
|
|
H2O America
|
222,451
|
13,643
|
|
|
Middlesex Water Co.
|
105,361
|
6,037
|
|
|
York Water Co.
|
91,703
|
2,840
|
|
|
|
|
3,817,852
|
|
Total Common Stocks (Cost $77,778,461)
|
130,407,201
|
||
|
Temporary Cash Investments (0.3%)
|
|||
|
Money Market Fund (0.3%)
|
|||
|
2,3
|
Vanguard Market Liquidity Fund, 3.718% (Cost $394,859)
|
3,949,257
|
394,886
|
|
Total Investments (99.9%) (Cost $78,173,320)
|
130,802,087
|
||
|
Other Assets and Liabilities-Net (0.1%)
|
97,778
|
||
|
Net Assets (100%)
|
130,899,865
|
||
|
Cost is in $000.
|
|||
|
•
|
See Note A in Notes to Financial Statements.
|
|
*
|
Non-income-producing security.
|
|
1
|
Includes partial security positions on loan to broker-dealers. The total value of securities on loan is $7,721.
|
|
2
|
Affiliated money market fund available only to Vanguard funds and certain trusts and accounts managed by Vanguard. Rate shown is the 7-day yield.
|
|
3
|
Collateral of $7,892 was received for securities on loan.
|
|
Futures Contracts
|
||||
|
|
|
|
($000)
|
|
|
|
Expiration
|
Number of
Long (Short)
Contracts
|
Notional
Amount
|
Value and
Unrealized
Appreciation
(Depreciation)
|
|
Long Futures Contracts
|
||||
|
E-mini S&P 500 Index
|
September 2026
|
262
|
98,502
|
(547)
|
|
Over-the-Counter Total Return Swaps
|
||||||
|
Reference Entity
|
Termination
Date
|
Counterparty
|
Notional
Amount
($000)
|
Floating
Interest Rate
Received
(Paid)1
(%)
|
Value and
Unrealized
Appreciation
($000)
|
Value and
Unrealized
(Depreciation)
($000)
|
|
Elevance Health Inc.
|
2/1/2027
|
CITNA
|
10,221
|
(4.130
)
|
-
|
(186)
|
|
Goldman Sachs Group Inc.
|
8/31/2027
|
BANA
|
85,092
|
(4.445
)
|
-
|
(2,486)
|
|
Kroger Co.
|
2/1/2027
|
GSI
|
56,560
|
(3.630
)
|
1,089
|
-
|
|
Raymond James Financial Inc.
|
2/1/2027
|
CITNA
|
8,143
|
(4.183
)
|
375
|
-
|
|
Visa Inc. Class A
|
8/31/2026
|
BANA
|
233,832
|
(3.620
)
|
2,181
|
-
|
|
|
3,645
|
(2,672)
|
||||
|
1
|
Based on Overnight Bank Funding Rate as of the most recent reset date. Floating interest payment received/(paid) monthly.
|
|
|
BANA-Bank of America, N.A.
|
|
|
CITNA-Citibank, N.A.
|
|
|
GSI-Goldman Sachs International.
|
|
|
|
|
($000s, except shares and per-share amounts)
|
Amount
|
|
Assets
|
|
|
Investments in Securities, at Value1
|
|
|
Unaffiliated Issuers (Cost $77,778,461)
|
130,407,201
|
|
Affiliated Issuers (Cost $394,859)
|
394,886
|
|
Total Investments in Securities
|
130,802,087
|
|
Investment in Vanguard
|
2,771
|
|
Cash
|
73
|
|
Cash Collateral Pledged-Futures Contracts
|
5,580
|
|
Receivables for Accrued Income
|
101,592
|
|
Receivables for Capital Shares Issued
|
4,947
|
|
Variation Margin Receivable-Futures Contracts
|
521
|
|
Unrealized Appreciation-Over-the-Counter Swap Contracts
|
3,645
|
|
Other Assets
|
20
|
|
Total Assets
|
130,921,236
|
|
Liabilities
|
|
|
Payables for Investment Securities Purchased
|
1,771
|
|
Collateral for Securities on Loan
|
7,892
|
|
Payables for Capital Shares Redeemed
|
6,492
|
|
Payables to Vanguard
|
2,544
|
|
Unrealized Depreciation-Over-the-Counter Swap Contracts
|
2,672
|
|
Total Liabilities
|
21,371
|
|
Net Assets
|
130,899,865
|
|
1 Includes $7,721 of securities on loan.
|
|
|
At July 31, 2026, net assets consisted of:
|
|
|
|
|
|
Paid-in Capital
|
80,311,266
|
|
Total Distributable Earnings (Loss)
|
50,588,599
|
|
Net Assets
|
130,899,865
|
|
|
|
|
ETF Shares-Net Assets
|
|
|
Applicable to 465,695,866 outstanding $.001 par value shares of
beneficial interest (unlimited authorization)
|
111,359,571
|
|
Net Asset Value Per Share-ETF Shares
|
$239.13
|
|
|
|
|
Admiral™ Shares-Net Assets
|
|
|
Applicable to 301,114,889 outstanding $.001 par value shares of
beneficial interest (unlimited authorization)
|
19,540,294
|
|
Net Asset Value Per Share-Admiral Shares
|
$64.89
|
|
|
|
|
|
Six Months Ended
July 31, 2026
|
|
|
($000)
|
|
Investment Income
|
|
|
Income
|
|
|
Dividends1
|
1,027,476
|
|
Interest2
|
12,519
|
|
Securities Lending-Net
|
12
|
|
Total Income
|
1,040,007
|
|
Expenses
|
|
|
The Vanguard Group-Note C
|
|
|
Investment Advisory Services
|
348
|
|
Management and Administrative-ETF Shares
|
18,097
|
|
Management and Administrative-Admiral Shares
|
5,946
|
|
Marketing and Distribution-ETF Shares
|
1,526
|
|
Marketing and Distribution-Admiral Shares
|
398
|
|
Custodian Fees
|
184
|
|
Shareholders' Reports-ETF Shares
|
812
|
|
Shareholders' Reports-Admiral Shares
|
105
|
|
Trustees' Fees and Expenses
|
30
|
|
Other Expenses
|
72
|
|
Total Expenses
|
27,518
|
|
Net Investment Income
|
1,012,489
|
|
Realized Net Gain (Loss)
|
|
|
Investment Securities Sold2,3
|
2,286,712
|
|
Futures Contracts
|
2,140
|
|
Swap Contracts
|
45,788
|
|
Realized Net Gain (Loss)
|
2,334,640
|
|
Change in Unrealized Appreciation (Depreciation)
|
|
|
Investment Securities2
|
5,866,769
|
|
Futures Contracts
|
(1,218
)
|
|
Swap Contracts
|
1,519
|
|
Change in Unrealized Appreciation (Depreciation)
|
5,867,070
|
|
Net Increase (Decrease) in Net Assets Resulting from Operations
|
9,214,199
|
|
1
|
Dividends are net of foreign withholding taxes of $96.
|
|
2
|
Interest income, realized net gain (loss), and change in unrealized appreciation (depreciation) from an affiliated company of the fund were $12,313, ($55), and ($23), respectively. Purchases and sales are for temporary
cash investment purposes.
|
|
3
|
Includes $2,800,484 of net gain (loss) resulting from in-kind redemptions.
|
|
|
||
|
|
Six Months Ended
July 31,
2026
|
Year Ended
January 31,
2026
|
|
|
($000)
|
($000)
|
|
Increase (Decrease) in Net Assets
|
||
|
Operations
|
||
|
Net Investment Income
|
1,012,489
|
1,897,675
|
|
Realized Net Gain (Loss)
|
2,334,640
|
2,891,280
|
|
Change in Unrealized Appreciation (Depreciation)
|
5,867,070
|
8,903,547
|
|
Net Increase (Decrease) in Net Assets Resulting from Operations
|
9,214,199
|
13,692,502
|
|
Distributions
|
||
|
ETF Shares
|
(848,825
)
|
(1,611,638
)
|
|
Admiral Shares
|
(147,622
)
|
(284,573
)
|
|
Total Distributions
|
(996,447
)
|
(1,896,211
)
|
|
Capital Share Transactions
|
||
|
ETF Shares
|
1,302,849
|
3,637,560
|
|
Admiral Shares
|
(134,296
)
|
352,495
|
|
Net Increase (Decrease) from Capital Share Transactions
|
1,168,553
|
3,990,055
|
|
Total Increase (Decrease)
|
9,386,305
|
15,786,346
|
|
Net Assets
|
||
|
Beginning of Period
|
121,513,560
|
105,727,214
|
|
End of Period
|
130,899,865
|
121,513,560
|
|
ETF Shares
|
|
|
|
|
|
|
|
For a Share Outstanding
Throughout Each Period
|
Six Months
Ended
July 31,
2026
|
Year Ended January 31,
|
||||
|
2026
|
2025
|
2024
|
2023
|
2022
|
||
|
Net Asset Value, Beginning of Period
|
$224.01
|
$202.26
|
$172.53
|
$156.26
|
$162.69
|
$137.11
|
|
Investment Operations
|
||||||
|
Net Investment Income1
|
1.863
|
3.560
|
3.381
|
3.185
|
2.982
|
2.736
|
|
Net Realized and Unrealized Gain (Loss) on Investments
|
15.089
|
21.748
|
29.728
|
16.293
|
(6.439)
|
25.504
|
|
Total from Investment Operations
|
16.952
|
25.308
|
33.109
|
19.478
|
(3.457)
|
28.240
|
|
Distributions
|
||||||
|
Dividends from Net Investment Income
|
(1.832)
|
(3.558)
|
(3.379)
|
(3.208)
|
(2.973)
|
(2.660)
|
|
Distributions from Realized Capital Gains
|
-
|
-
|
-
|
-
|
-
|
-
|
|
Total Distributions
|
(1.832)
|
(3.558)
|
(3.379)
|
(3.208)
|
(2.973)
|
(2.660)
|
|
Net Asset Value, End of Period
|
$239.13
|
$224.01
|
$202.26
|
$172.53
|
$156.26
|
$162.69
|
|
Total Return
|
7.63%
|
12.66%
|
19.34%
|
12.66%
|
-2.02%
|
20.71%
|
|
Ratios/Supplemental Data
|
|
|
|
|
|
|
|
Net Assets, End of Period (Millions)
|
$111,360
|
$103,085
|
$89,405
|
$73,991
|
$66,062
|
$65,589
|
|
Ratio of Total Expenses to Average Net Assets
|
0.04%
|
0.05%
|
0.06%2
|
0.06%2
|
0.06%2
|
0.06%
|
|
Ratio of Net Investment Income to Average Net Assets
|
1.64%
|
1.72%
|
1.78%
|
1.99%
|
1.96%
|
1.74%
|
|
Portfolio Turnover Rate3
|
4%
|
8%
|
11%
|
13%
|
12%
|
26%
|
|
The expense ratio and net investment income ratio for the current period have been annualized.
|
||||||
|
1
|
Calculated based on average shares outstanding.
|
|
2
|
The ratio of expenses to average net assets for the period net of reduction from custody fee offset arrangements was 0.06%.
|
|
3
|
Excludes the value of portfolio securities received or delivered as a result of in-kind purchases or redemptions of the fund's capital shares, including ETF Creation Units.
|
|
Admiral Shares
|
|
|
|
|
|
|
|
For a Share Outstanding
Throughout Each Period
|
Six Months
Ended
July 31,
2026
|
Year Ended January 31,
|
||||
|
2026
|
2025
|
2024
|
2023
|
2022
|
||
|
Net Asset Value, Beginning of Period
|
$60.79
|
$54.89
|
$46.82
|
$42.41
|
$44.15
|
$37.21
|
|
Investment Operations
|
||||||
|
Net Investment Income1
|
.497
|
.955
|
.907
|
.856
|
.801
|
.734
|
|
Net Realized and Unrealized Gain (Loss) on Investments
|
4.091
|
5.900
|
8.070
|
4.416
|
(1.743)
|
6.920
|
|
Total from Investment Operations
|
4.588
|
6.855
|
8.977
|
5.272
|
(.942)
|
7.654
|
|
Distributions
|
||||||
|
Dividends from Net Investment Income
|
(.488)
|
(.955)
|
(.907)
|
(.862)
|
(.798)
|
(.714)
|
|
Distributions from Realized Capital Gains
|
-
|
-
|
-
|
-
|
-
|
-
|
|
Total Distributions
|
(.488)
|
(.955)
|
(.907)
|
(.862)
|
(.798)
|
(.714)
|
|
Net Asset Value, End of Period
|
$64.89
|
$60.79
|
$54.89
|
$46.82
|
$42.41
|
$44.15
|
|
Total Return2
|
7.61%
|
12.63%
|
19.32%
|
12.64%
|
-2.02%
|
20.67%
|
|
Ratios/Supplemental Data
|
|
|
|
|
|
|
|
Net Assets, End of Period (Millions)
|
$19,540
|
$18,428
|
$16,322
|
$13,962
|
$12,471
|
$12,903
|
|
Ratio of Total Expenses to Average Net Assets
|
0.07%
|
0.07%
|
0.08%3
|
0.08%3
|
0.08%3
|
0.08%
|
|
Ratio of Net Investment Income to Average Net Assets
|
1.61%
|
1.70%
|
1.77%
|
1.97%
|
1.94%
|
1.72%
|
|
Portfolio Turnover Rate4
|
4%
|
8%
|
11%
|
13%
|
12%
|
26%
|
|
The expense ratio and net investment income ratio for the current period have been annualized.
|
||||||
|
1
|
Calculated based on average shares outstanding.
|
|
2
|
Total returns do not include account service fees that may have applied in the periods shown. Fund prospectuses provide information about any applicable account service fees.
|
|
3
|
The ratio of expenses to average net assets for the period net of reduction from custody fee offset arrangements was 0.08%.
|
|
4
|
Excludes the value of portfolio securities received or delivered as a result of in-kind purchases or redemptions of the fund's capital shares, including ETF Creation Units.
|
|
|
Level 1
($000)
|
Level 2
($000)
|
Level 3
($000)
|
Total
($000)
|
|
Investments
|
|
|
|
|
|
Assets
|
|
|
|
|
|
Common Stocks
|
130,407,201
|
-
|
-
|
130,407,201
|
|
Temporary Cash Investments
|
394,886
|
-
|
-
|
394,886
|
|
Total
|
130,802,087
|
-
|
-
|
130,802,087
|
|
Derivative Financial Instruments
|
|
|
|
|
|
Assets
|
|
|
|
|
|
Swap Contracts
|
-
|
3,645
|
-
|
3,645
|
|
Liabilities
|
|
|
|
|
|
Futures Contracts1
|
(547)
|
-
|
-
|
(547)
|
|
Swap Contracts
|
-
|
(2,672)
|
-
|
(2,672)
|
|
Total
|
(547)
|
(2,672)
|
-
|
(3,219)
|
|
1
|
Includes cumulative appreciation (depreciation) on futures contracts and centrally cleared swaps, if any, as reported in the Schedule of Investments. Only current day's variation margin is reported within the Statement
of Assets and Liabilities.
|
|
|
Amount
($000)
|
|
Tax Cost
|
78,264,527
|
|
Gross Unrealized Appreciation
|
54,103,034
|
|
Gross Unrealized Depreciation
|
(1,566,021)
|
|
Net Unrealized Appreciation (Depreciation)
|
52,537,013
|
|
|
Six Months Ended
July 31, 2026
|
Year Ended
January 31, 2026
|
||
|
|
Amount
($000)
|
Shares
(000)
|
Amount
($000)
|
Shares
(000)
|
|
ETF Shares
|
||||
|
Issued
|
5,542,414
|
24,694
|
11,071,909
|
54,943
|
|
Issued in Lieu of Cash Distributions
|
-
|
-
|
-
|
-
|
|
Redeemed
|
(4,239,565)
|
(19,175)
|
(7,434,349)
|
(36,800)
|
|
Net Increase (Decrease)-ETF Shares
|
1,302,849
|
5,519
|
3,637,560
|
18,143
|
|
Admiral Shares
|
||||
|
Issued
|
1,040,304
|
16,850
|
2,704,097
|
47,722
|
|
Issued in Lieu of Cash Distributions
|
123,018
|
2,032
|
239,326
|
4,241
|
|
Redeemed
|
(1,297,618)
|
(20,901)
|
(2,590,928)
|
(46,202)
|
|
Net Increase (Decrease)-Admiral Shares
|
(134,296)
|
(2,019)
|
352,495
|
5,761
|
Item 8: Changes in and Disagreements with Accountants for Open-End Management Investment Companies.
Not applicable.
Item 9: Proxy Disclosures for Open-End Management Investment Companies.
Not applicable.
Item 10: Remuneration Paid to Directors, Officers, and Others of Open-End Management Investment Companies.
Not applicable. The Trustees' Fees and Expenses are included in the financial statements filed under Item 7 of this Form.
Item 11: Statement Regarding Basis for Approval of Investment Advisory Contracts.
Trustees Approve Advisory Arrangement - Dividend Appreciation Index Fund
A majority of independent trustees of the board of Vanguard Dividend Appreciation Index Fund (Trustees) have renewed the fund's investment advisory arrangement with The Vanguard Group, Inc. (Vanguard), which provides investment advisory services to the fund through its subsidiary, Vanguard Portfolio Management LLC (VPM). The trustees determined that continuing the advisory arrangement was in the best interests of the fund and its shareholders.
The Trustees based their decisions upon an evaluation of VPM's investment staff, portfolio management process, and performance. This evaluation included information provided by Vanguard's Oversight and Manager Search team, which is responsible for fund and advisor oversight and product management.
The Oversight and Manager Search team met regularly with the advisor and made presentations to the Trustees during the fiscal year that directed the Trustees' focus to relevant information and topics.
The board, or an investment committee made up of Trustees, also received information throughout the year during advisor presentations conducted by the Oversight and Manager Search team. For each advisor presentation, the Trustees were provided with letters and reports that included information about, among other things, the advisory firm and the advisor's assessment of the investment environment, portfolio performance, and portfolio characteristics.
In addition, the Trustees received periodic reports throughout the year, which included information about the fund's performance relative to its peers and benchmark, as applicable, and updates, as needed, on the Oversight and Manager Search team's ongoing assessment of the advisor.
Prior to their meeting, the trustees were provided with a memo and materials that summarized the information they received over the course of the year. The Trustees considered the factors discussed below, among others. However, no single factor determined whether to approve the arrangement. Rather, it was the totality of the circumstances that drove the Trustee's decisions.
Nature, extent, and quality of services
The Trustees considered the quality of the investment management services over both the short and long term and took into account the organizational depth and stability of Vanguard and VPM. The Trustees considered that Vanguard has been managing investments for more than four decades. The Strategic Equity Index Management team (SE), now within VPM, adheres to the same sound, disciplined investment management process and has considerable experience, stability and depth. In its management of other Vanguard passive and active equity funds and portfolios, the team has a track record of consistent performance as a result of its disciplined investment processes. SE has specific expertise and experience managing U.S. style-box, sector, and smart-beta index strategies, effectively navigating index reconstitutions and mitigating transactions costs to deliver tight tracking error while opportunistically seeking to add excess returns through sophisticated trading strategies and superior access to corporate actions.
The Trustees concluded that VPM's experience, stability, depth, and performance, among other factors, warranted continuation of the advisory arrangement.
Investment performance
The Trustees considered the fund's short- and long-term performance, including any periods of outperformance or underperformance compared with a relevant benchmark index and peer group. The Trustees concluded the performance was such that the advisory arrangement should continue.
Cost
The Trustees concluded that the fund's expense ratio was below the average expense ratio charged by funds in its peer group and that the fund's advisory expenses were also below the peer-group average.
The Trustees do not conduct a profitability analysis of Vanguard in providing investment advisory services through VPM because of Vanguard's unique structure. Unlike most other mutual fund management companies, Vanguard is owned by the funds it oversees.
The benefit of economies of scale
The Trustees concluded that the fund's arrangement with Vanguard, and services rendered through VPM, ensure that the fund will realize economies of scale as it grows, with the cost to shareholders declining as fund assets increase.
The Trustees will consider whether to renew the advisory arrangement again within a one-year period.
Trustees Approve Advisory Arrangement - Energy Opportunities Fund
A majority of independent trustees of the board of Vanguard Energy Opportunities Fund (Trustees) has renewed the fund's investment advisory arrangement with Wellington Management Company LLP (Wellington Management). The Trustees determined that renewing the fund's advisory arrangement was in the best interests of the fund and its shareholders.
The Trustees based their decision upon an evaluation of the advisor's investment staff, portfolio management process, and performance. This evaluation included information provided to the Trustees by Vanguard's Oversight and Manager Search team (OMS), which is responsible for fund and advisor oversight and product management. OMS met regularly with the advisor and made presentations to the Trustees during the fiscal year that directed their focus to relevant information and topics.
The Trustees also received information throughout the year during advisor presentations conducted by the Oversight and Manager Search team. For each advisor presentation, the Trustees were provided with letters and reports that included information about, among other things, the advisory firm and the advisor's assessment of the investment environment, portfolio performance, and portfolio characteristics.
In addition, the Trustees received periodic reports throughout the year, which included information about each fund's performance relative to its peers and benchmark, as applicable, and updates, as needed, on the Oversight and Manager Search team's ongoing assessment of the advisor.
Prior to their meeting, the Trustees were provided with a memo and materials that summarized the information they received over the course of the year. They also considered the factors discussed below, among others. However, no single factor determined whether the Trustees approved the arrangement. Rather, it was the totality of the circumstances that drove the Trustees' decision.
Nature, extent, and quality of services
The Trustees reviewed the quality of the fund's investment management services over both the short and long term and took into account the organizational depth and stability of the advisor. The board considered that Wellington Management, founded in 1928, is among the nation's oldest and most respected institutional investment managers. The investment team uses a bottom-up approach in which stocks are selected based on the advisor's estimates of fundamental investment value. Fundamental research focuses on the quality of a company's assets, the company's internal reinvestment opportunities, and management quality. The firm has advised the fund since its inception in 1984.
The Trustees concluded that the advisor's experience, stability, depth, and performance, among other factors, warranted continuation of the advisory arrangement.
Investment performance
The Trustees considered the fund's short- and long-term performance, including any periods of outperformance or underperformance compared with a relevant benchmark index and peer group. The Trustees concluded the performance was such that the advisory arrangement should continue.
Cost
The Trustees concluded that the fund's expense ratio was below the average expense ratio charged by funds in its peer group and that the fund's advisory fee rate was also below the peer-group average.
The Trustees did not consider the profitability of Wellington Management in determining whether to approve the advisory fee, because Wellington Management is independent of Vanguard and the advisory fee is the result of arm's-length negotiations.
The benefit of economies of scale
The Trustees concluded that the fund's shareholders benefit from economies of scale because of breakpoints in the fund's advisory fee schedule. The breakpoints reduce the effective rate of the fee as the fund's assets increase.
The Trustees will consider whether to renew the advisory arrangement again within a one-year period.
Trustees Approve Advisory Arrangement - Health Care Fund
A majority of independent trustees of the board of Vanguard Health Care Fund (Trustees) has renewed the fund's investment advisory arrangement with Wellington Management Company LLP (Wellington Management). The Trustees determined that renewing the fund's advisory arrangement was in the best interests of the fund and its shareholders.
The Trustees based their decision upon an evaluation of the advisor's investment staff, portfolio management process, and performance. This evaluation included information provided to the Trustees by Vanguard's Oversight and Manager Search team (OMS), which is responsible for fund and advisor oversight and product management. OMS met regularly with the advisor and made presentations to the Trustees during the fiscal year that directed their focus to relevant information and topics.
The Trustees also received information throughout the year during advisor presentations conducted by the Oversight and Manager Search team. For each advisor presentation, the Trustees were provided with letters and reports that included information about, among other things, the advisory firm and the advisor's assessment of the investment environment, portfolio performance, and portfolio characteristics.
In addition, the Trustees received periodic reports throughout the year, which included information about each fund's performance relative to its peers and benchmark, as applicable, and updates, as needed, on the Oversight and Manager Search team's ongoing assessment of the advisor.
Prior to their meeting, the Trustees were provided with a memo and materials that summarized the information they received over the course of the year. They also considered the factors discussed below, among others. However, no single factor determined whether the Trustees approved the arrangement. Rather, it was the totality of the circumstances that drove the Trustees' decision.
Nature, extent, and quality of services
The Trustees reviewed the quality of the fund's investment management services over both the short and long term and took into account the organizational depth and stability of the advisor. The board considered that Wellington Management, founded in 1928, is among the nation's oldest and most respected institutional investment managers. The portfolio manager is aided by a team of experienced Global Industry Analysts who cover health care industries. This health care team uses intensive fundamental analysis and deep knowledge of health care science and technology to identify companies with high-quality balance sheets, strong management, and the potential for new products that will lead to above-average growth in revenue and earnings. The advisor invests in stocks broadly representing the health care industry, seeking to maintain exposure across five primary subsectors: large-cap biotech/pharmaceuticals, mid-cap biotech/pharmaceuticals, small-cap biotech/pharmaceuticals, health care services, and medical technology. Wellington Management has advised the fund since its inception in 1984.
The Trustees concluded that the advisor's experience, stability, depth, and performance, among other factors, warranted continuation of the advisory arrangement.
Investment performance
The Trustees considered the fund's short- and long-term performance, including any periods of outperformance or underperformance compared with a relevant benchmark index and peer group. The Trustees concluded the performance was such that the advisory arrangement should continue.
Cost
The Trustees concluded that the fund's expense ratio was below the average expense ratio charged by funds in its peer group and that the fund's advisory fee rate was also below the peer-group average.
The Trustees did not consider the profitability of Wellington Management in determining whether to approve the advisory fee, because Wellington Management is independent of Vanguard and the advisory fee is the result of arm's-length negotiations.
The benefit of economies of scale
The Trustees concluded that the fund's shareholders benefit from economies of scale because of breakpoints in the fund's advisory fee schedule. The breakpoints reduce the effective rate of the fee as the fund's assets increase.
The Trustees will consider whether to renew the advisory arrangement again within a one-year period.
Item 12: Disclosure of Proxy Voting Policies and Procedures for Closed-End Management Investment Companies.
Not applicable.
Item 13: Portfolio Managers of Closed-End Management Investment Companies.
Not applicable.
Item 14: Purchase of Equity Securities by Closed-End Management Investment Company and Affiliated Purchasers.
Not applicable.
Item 15: Submission of Matters to a Vote of Security Holders.
Not applicable.
Item 16: Controls and Procedures.
(a) Disclosure Controls and Procedures. The Principal Executive and Financial Officers concluded that the Registrant's Disclosure Controls and Procedures are effective based on their evaluation of the Disclosure Controls and Procedures as of a date within 90 days of the filing date of this report.
(b) Internal Control Over Financial Reporting. There were no changes in the Registrant's Internal Control Over Financial Reporting that occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, the Registrant's internal control over financial reporting.
Item 17: Disclosure of Securities Lending Activities for Closed-End Management Investment Companies.
Not applicable.
Item 18: Recovery of Erroneously Awarded Compensation
Not applicable.
Item 19: Exhibits.
| (a)(1) | Not applicable. |
| (a)(2) | Certifications filed herewith. |
| (a)(2) | Certifications filed herewith. |
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| VANGUARD SPECIALIZED FUNDS | ||
| BY: | /s/ SALIM RAMJI* | |
| SALIM RAMJI | ||
| CHIEF EXECUTIVE OFFICER | ||
Date: September 21, 2026
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
| VANGUARD SPECIALIZED FUNDS | ||
| BY: | /s/ SALIM RAMJI* | |
| SALIM RAMJI | ||
| CHIEF EXECUTIVE OFFICER | ||
Date: September 21, 2026
| VANGUARD SPECIALIZED FUNDS | ||
| BY: | /s/ CHRISTINE BUCHANAN* | |
| CHRISTINE BUCHANAN | ||
| CHIEF FINANCIAL OFFICER | ||
Date: September 21, 2026
| * By: | /s/ Natalie Lamarque |
Natalie Lamarque, pursuant to a Power of Attorney filed on December 19, 2025 (see File Number 33-49023), and to a Power of Attorney filed on February 27, 2026 (see File Number 333-177613), Incorporated by Reference.